UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


(Mark One)
☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November ~~27, 2021~~26, 2022


OR
o			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________ to ________

Commission File Number: 001-38115

___________________________________________________________________________________________________________

The Simply Good Foods Company

(Exact name of registrant as specified in its charter)


Delaware						82-1038121
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

1225 17th Street, Suite 1000

Denver, CO 80202

(Address of principal executive offices and zip code)

(303) 633-2840

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol

Name of each exchange on which registered

Common Stock, par value $0.01 per share

SMPL

Nasdaq

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Date File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~January 3,~~December 30, 2022, there were ~~96,132,194~~99,491,357 shares of common stock, par value $0.01 per share, issued and outstanding.

THE SIMPLY GOOD FOODS COMPANY AND SUBSIDIARIES

FORM 10-Q

FOR THE QUARTER ENDED NOVEMBER ~~27, 2021~~26, 2022

INDEX


		Page
PART I. Financial Information
Item 1.	Financial Statements (Unaudited)	3
	~~Condensed~~ Consolidated Balance Sheets	3
	~~Condensed~~ Consolidated Statements of Operations and Comprehensive Income	4
	~~Condensed~~ Consolidated Statements of Cash Flows	5
	~~Condensed~~ Consolidated Statements of Stockholders’ Equity	7
	Notes to Unaudited ~~Condensed~~ Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1918
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	2726
Item 4.	Controls and Procedures	2726
PART II. Other Information
Item 1.	Legal Proceedings	2827
Item 1A.	Risk Factors	2827
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2827
Item 3.	Defaults Upon Senior Securities	2827
Item 4.	Mine Safety Disclosures	2827
Item 5.	Other Information	2827
Item 6.	Exhibits	2928
	Signatures	3029

PART I. Financial Information

Item 1. Financial Statements (Unaudited)

The Simply Good Foods Company and Subsidiaries

~~Condensed~~ Consolidated Balance Sheets

(Unaudited, dollars in thousands, except share and per share data)


		November 27, 2021		August 28, 2021			November 26, 2022		August 27, 2022
Assets	Assets					Assets
Current assets:	Current assets:					Current assets:
Cash	Cash	$	35,447	$	75,345	Cash	$	54,144	$	67,494
Accounts receivable, net	Accounts receivable, net	125,195		111,456		Accounts receivable, net	158,883		132,667
Inventories	Inventories	112,433		97,269		Inventories	124,119		125,479
Prepaid expenses	Prepaid expenses	4,893		4,902		Prepaid expenses	5,564		5,027
Other current assets	Other current assets	9,669		9,694		Other current assets	14,590		20,934
Total current assets	Total current assets	287,637		298,666		Total current assets	357,300		351,601

Long-term assets:	Long-term assets:					Long-term assets:
Property and equipment, net	Property and equipment, net	17,416		16,584		Property and equipment, net	17,668		18,157
Intangible assets, net	Intangible assets, net	1,135,068		1,139,041		Intangible assets, net	1,119,347		1,123,258
Goodwill	Goodwill	543,134		543,134		Goodwill	543,134		543,134
Other long-term assets	Other long-term assets	60,081		54,792		Other long-term assets	55,614		58,099
Total assets	Total assets	$	2,043,336	$	2,052,217	Total assets	$	2,093,063	$	2,094,249

Liabilities and stockholders’ equity	Liabilities and stockholders’ equity					Liabilities and stockholders’ equity
Current liabilities:	Current liabilities:					Current liabilities:
Accounts payable	Accounts payable	$	44,811	$	59,713	Accounts payable	$	55,249	$	62,149
Accrued interest	Accrued interest	—		60		Accrued interest	257		160
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	35,665		53,606		Accrued expenses and other current liabilities	25,158		39,675
Current maturities of long-term debt	Current maturities of long-term debt	289		285		Current maturities of long-term debt	250		264
Total current liabilities	Total current liabilities	80,765		113,664		Total current liabilities	80,914		102,248

Long-term liabilities:	Long-term liabilities:					Long-term liabilities:
Long-term debt, less current maturities	Long-term debt, less current maturities	427,017		451,269		Long-term debt, less current maturities	396,994		403,022
Deferred income taxes	Deferred income taxes	100,499		93,755		Deferred income taxes	108,894		105,676
Warrant liability		177,152		159,835

Other long-term liabilities	Other long-term liabilities	48,296		44,890		Other long-term liabilities	42,905		44,639
Total liabilities	Total liabilities	833,729		863,413		Total liabilities	629,707		655,585
See commitments and contingencies (Note 9)	See commitments and contingencies (Note 9)	0		0		See commitments and contingencies (Note 9)

Stockholders’ equity:	Stockholders’ equity:					Stockholders’ equity:
Preferred stock, $0.01 par value, 100,000,000 shares authorized, none issued	Preferred stock, $0.01 par value, 100,000,000 shares authorized, none issued	—		—		Preferred stock, $0.01 par value, 100,000,000 shares authorized, none issued	—		—
Common stock, $0.01 par value, 600,000,000 shares authorized, 96,130,441 and 95,882,908 shares issued at November 27, 2021 and August 28, 2021, respectively		961		959
Treasury stock, 98,234 shares at cost at November 27, 2021 and August 28, 2021		(2,145)		(2,145)
Common stock, $0.01 par value, 600,000,000 shares authorized, 101,856,457 and 101,322,834 shares issued at November 26, 2022 and August 27, 2022, respectively						Common stock, $0.01 par value, 600,000,000 shares authorized, 101,856,457 and 101,322,834 shares issued at November 26, 2022 and August 27, 2022, respectively	1,019		1,013
Treasury stock, 2,365,100 shares and 1,818,754 shares at cost at November 26, 2022 and August 27, 2022, respectively						Treasury stock, 2,365,100 shares and 1,818,754 shares at cost at November 26, 2022 and August 27, 2022, respectively	(78,451)		(62,003)
Additional paid-in-capital	Additional paid-in-capital	1,084,690		1,085,001		Additional paid-in-capital	1,292,720		1,287,224
Retained earnings	Retained earnings	126,959		105,807		Retained earnings	250,241		214,381
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(858)		(818)		Accumulated other comprehensive loss	(2,173)		(1,951)
Total stockholders’ equity	Total stockholders’ equity	1,209,607		1,188,804		Total stockholders’ equity	1,463,356		1,438,664
Total liabilities and stockholders’ equity	Total liabilities and stockholders’ equity	$	2,043,336	$	2,052,217	Total liabilities and stockholders’ equity	$	2,093,063	$	2,094,249

See accompanying notes to the unaudited condensed consolidated financial statements.

Table of Contents

The Simply Good Foods Company and Subsidiaries

~~Condensed~~ Consolidated Statements of Operations and Comprehensive Income

(Unaudited, dollars in thousands, except share and per share data)


		Thirteen Weeks Ended				Thirteen Weeks Ended
		November 27, 2021		November 28, 2020				November 26, 2022		November 27, 2021
Net sales	Net sales	$	281,265	$	231,152		Net sales	$	300,878	$	281,265
Cost of goods sold	Cost of goods sold	164,710		137,111			Cost of goods sold	189,886		164,710
Gross profit	Gross profit	116,555		94,041			Gross profit	110,992		116,555

Operating expenses:	Operating expenses:						Operating expenses:
Selling and marketing	Selling and marketing	30,527		25,195			Selling and marketing	28,534		30,527
General and administrative	General and administrative	23,702		25,415			General and administrative	25,641		23,702
Depreciation and amortization	Depreciation and amortization	4,320		4,244			Depreciation and amortization	4,327		4,320

Total operating expenses	Total operating expenses	58,549		54,854			Total operating expenses	58,502		58,549

Income from operations	Income from operations	58,006		39,187			Income from operations	52,490		58,006

Other income (expense):	Other income (expense):						Other income (expense):
Interest income	Interest income	1		3			Interest income	7		1
Interest expense	Interest expense	(6,371)		(8,372)			Interest expense	(7,055)		(6,371)
(Loss) gain in fair value change of warrant liability		(17,317)		20,453
Loss in fair value change of warrant liability							Loss in fair value change of warrant liability	—		(17,317)

(Loss) gain on foreign currency transactions		(353)		9
Gain (loss) on foreign currency transactions							Gain (loss) on foreign currency transactions	108		(353)
Other income	Other income	9		47			Other income	6		9
Total other (expense) income		(24,031)		12,140
Total other expense							Total other expense	(6,934)		(24,031)

Income before income taxes	Income before income taxes	33,975		51,327			Income before income taxes	45,556		33,975
Income tax expense	Income tax expense	12,823		8,374			Income tax expense	9,696		12,823
Net income	Net income	$	21,152	$	42,953		Net income	$	35,860	$	21,152

Other comprehensive income:	Other comprehensive income:						Other comprehensive income:
Foreign currency translation adjustments		$	(40)	$	(45)
Foreign currency translation							Foreign currency translation	$	(222)	$	(40)
Comprehensive income	Comprehensive income	$	21,112	$	42,908		Comprehensive income	$	35,638	$	21,112

Earnings per share from net income:	Earnings per share from net income:						Earnings per share from net income:
Basic	Basic	$	0.22	$	0.45		Basic	$	0.36	$	0.22
Diluted	Diluted	$	0.22	$	0.23		Diluted	$	0.36	$	0.22
Weighted average shares outstanding:	Weighted average shares outstanding:						Weighted average shares outstanding:
Basic	Basic	95,856,845		95,538,111			Basic	99,200,557		95,856,845
Diluted	Diluted	97,861,573		99,763,119			Diluted	100,723,036		97,861,573

See accompanying notes to the unaudited condensed consolidated financial statements.

Table of Contents

The Simply Good Foods Company and Subsidiaries

~~Condensed~~ Consolidated Statements of Cash Flows

(Unaudited, dollars in thousands)


		Thirteen Weeks Ended					Thirteen Weeks Ended
		November 27, 2021		November 28, 2020			November 26, 2022		November 27, 2021
Operating activities	Operating activities					Operating activities
Net income	Net income	$	21,152	$	42,953	Net income	$	35,860	$	21,152
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:						Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	Depreciation and amortization	4,741		4,513		Depreciation and amortization	4,952		4,741
Amortization of deferred financing costs and debt discount	Amortization of deferred financing costs and debt discount	821		1,077		Amortization of deferred financing costs and debt discount	532		821
Stock compensation expense	Stock compensation expense	2,605		1,110		Stock compensation expense	3,313		2,605
Loss (gain) in fair value change of warrant liability		17,317		(20,453)
Change in fair value change of warrant liability						Change in fair value change of warrant liability	—		17,317
Estimated credit losses	Estimated credit losses	15		—		Estimated credit losses	(141)		15
Unrealized loss on foreign currency transactions		353		9
Unrealized gain on foreign currency transactions						Unrealized gain on foreign currency transactions	(108)		353
Deferred income taxes	Deferred income taxes	6,687		4,400		Deferred income taxes	3,206		6,687

Amortization of operating lease right-of-use asset	Amortization of operating lease right-of-use asset	1,643		1,182		Amortization of operating lease right-of-use asset	1,660		1,643
Loss on operating lease right-of-use asset impairment		—		354

Gain on lease termination	Gain on lease termination	(30)		—		Gain on lease termination	—		(30)

Other	Other	(27)		402		Other	571		(27)
Changes in operating assets and liabilities:	Changes in operating assets and liabilities:					Changes in operating assets and liabilities:
Accounts receivable, net	Accounts receivable, net	(13,993)		(8,604)		Accounts receivable, net	(26,288)		(13,993)
Inventories	Inventories	(15,331)		(18,138)		Inventories	638		(15,331)
Prepaid expenses	Prepaid expenses	—		(558)		Prepaid expenses	(541)		—
Other current assets	Other current assets	(98)		2,874		Other current assets	8,631		(98)
Accounts payable	Accounts payable	(14,220)		8,216		Accounts payable	(6,609)		(14,220)
Accrued interest	Accrued interest	(60)		(240)		Accrued interest	97		(60)
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	(17,902)		(5,127)		Accrued expenses and other current liabilities	(14,843)		(17,902)
Other assets and liabilities	Other assets and liabilities	(1,002)		1,227		Other assets and liabilities	(2,212)		(1,002)
Net cash (used in) provided by operating activities		(7,329)		15,197
Net cash provided by (used in) operating activities						Net cash provided by (used in) operating activities	8,718		(7,329)

Investing activities	Investing activities					Investing activities
Purchases of property and equipment	Purchases of property and equipment	(2,691)		(93)		Purchases of property and equipment	(1,151)		(2,691)
Issuance of note receivable	Issuance of note receivable	(1,500)		—		Issuance of note receivable	—		(1,500)

Proceeds from sale of business		—		5,800

Investments in intangible and other assets	Investments in intangible and other assets	(186)		(114)		Investments in intangible and other assets	(87)		(186)
Net cash (used in) provided by investing activities		(4,377)		5,593
Net cash used in investing activities						Net cash used in investing activities	(1,238)		(4,377)

Financing activities	Financing activities					Financing activities
Proceeds from option exercises	Proceeds from option exercises	274		157		Proceeds from option exercises	4,563		274
Tax payments related to issuance of restricted stock units and performance stock units	Tax payments related to issuance of restricted stock units and performance stock units	(3,188)		(201)		Tax payments related to issuance of restricted stock units and performance stock units	(2,298)		(3,188)
Payments on finance lease obligations	Payments on finance lease obligations	(78)		(78)		Payments on finance lease obligations	(78)		(78)

Repurchase of common stock						Repurchase of common stock	(16,448)		—
Principal payments of long-term debt	Principal payments of long-term debt	(25,000)		(25,000)		Principal payments of long-term debt	(6,500)		(25,000)

Net cash used in financing activities	Net cash used in financing activities	(27,992)		(25,122)		Net cash used in financing activities	(20,761)		(27,992)

Cash and cash equivalents	Cash and cash equivalents					Cash and cash equivalents
Net decrease in cash	Net decrease in cash	(39,698)		(4,332)		Net decrease in cash	(13,281)		(39,698)
Effect of exchange rate on cash	Effect of exchange rate on cash	(200)		(39)		Effect of exchange rate on cash	(69)		(200)
Cash at beginning of period	Cash at beginning of period	75,345		95,847		Cash at beginning of period	67,494		75,345
Cash and cash equivalents at end of period	Cash and cash equivalents at end of period	$	35,447	$	91,476	Cash and cash equivalents at end of period	$	54,144	$	35,447

Table of Contents


		Thirteen Weeks Ended					Thirteen Weeks Ended
		November 27, 2021		November 28, 2020			November 26, 2022		November 27, 2021
Supplemental disclosures of cash flow information	Supplemental disclosures of cash flow information					Supplemental disclosures of cash flow information
Cash paid for interest	Cash paid for interest	$	5,731	$	7,535	Cash paid for interest	$	6,426	$	5,731
Cash paid for taxes	Cash paid for taxes	$	8,775	$	282	Cash paid for taxes	$	8	$	8,775
Non-cash investing and financing transactions	Non-cash investing and financing transactions					Non-cash investing and financing transactions
Non-cash proceeds from sale of business		$	—	$	3,000

Operating lease right-of-use assets exchanged for operating lease liabilities	Operating lease right-of-use assets exchanged for operating lease liabilities	$	5,551	$	306	Operating lease right-of-use assets exchanged for operating lease liabilities	$	—	$	5,551

See accompanying notes to the unaudited condensed consolidated financial statements.

Table of Contents

The Simply Good Foods Company and Subsidiaries

~~Condensed~~ Consolidated Statements of Stockholders’ Equity

(Unaudited, dollars in thousands, except share data)


		Common Stock			Treasury Stock			Additional Paid-In Capital				Retained Earnings		Accumulated Other Comprehensive Loss				Total					Common Stock						Treasury Stock			Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total
		Shares	Amount		Shares	Amount											Shares					Amount			Shares			Amount
Balance at August 28, 2021		95,882,908	$	959	98,234	$	(2,145)			$	1,085,001					$	105,807			$	(818)		$	1,188,804
Balance at August 27, 2022																					Balance at August 27, 2022		101,322,834			$	1,013		1,818,754	$	(62,003)		$	1,287,224		$	214,381		$	(1,951)		$	1,438,664
Net income	Net income	—	—		—	—		—				21,152		—				21,152			Net income		—			—			—	—		—			35,860			—			35,860
Stock-based compensation	Stock-based compensation	—	—		—	—		2,605				—		—				2,605			Stock-based compensation		—			—			—	—		3,237			—			—			3,237
Foreign currency translation adjustments	Foreign currency translation adjustments	—	—		—	—		—				—		(40)				(40)			Foreign currency translation adjustments		—			—			—	—		—			—			(222)			(222)

Repurchase of common stock																					Repurchase of common stock		—			—			546,346	(16,448)		—			—			—			(16,448)
Shares issued upon vesting of restricted stock units and performance stock units	Shares issued upon vesting of restricted stock units and performance stock units	227,729	2		—	—		(3,190)				—		—				(3,188)			Shares issued upon vesting of restricted stock units and performance stock units		180,342			2			—	—		(2,300)			—			—			(2,298)
Exercise of options to purchase common stock		19,804	—		—	—		274				—		—				274
Balance at November 27, 2021		96,130,441	$	961	98,234	$	(2,145)	$	1,084,690			$	126,959	$	(858)			$	1,209,607
Exercise of options and stock appreciation rights to purchase common stock																					Exercise of options and stock appreciation rights to purchase common stock		353,281			4			—	—		4,559			—			—			4,563
Balance at November 26, 2022																					Balance at November 26, 2022		101,856,457			$	1,019		2,365,100	$	(78,451)	$	1,292,720		$	250,241		$	(2,173)		$	1,463,356


		Common Stock			Treasury Stock			Additional Paid-In Capital				Retained Earnings		Accumulated Other Comprehensive Loss		Total							Common Stock					Treasury Stock			Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total
		Shares	Amount		Shares	Amount													Shares			Amount		Shares			Amount
Balance at August 29, 2020		95,751,845	$	958	98,234	$	(2,145)			$	1,076,472			$	64,927			$	(879)		$	1,139,333
Balance at August 28, 2021																				Balance at August 28, 2021			95,882,908		$	959		98,234	$	(2,145)		$	1,085,001		$	105,807		$	(818)		$	1,188,804
Net income	Net income	—	—		—	—		—				42,953		—		42,953				Net income			—		—			—	—		—			21,152			—			21,152
Stock-based compensation	Stock-based compensation	—	—		—	—		1,110				—		—		1,110				Stock-based compensation			—		—			—	—		2,605			—			—			2,605

Foreign currency translation adjustments	Foreign currency translation adjustments	—	—		—	—		—				—		(45)		(45)				Foreign currency translation adjustments			—		—			—	—		—			—			(40)			(40)
Shares issued upon vesting of restricted stock units		53,908	—		—	—		(201)				—		—		(201)
Shares issued upon vesting of restricted stock units and performance stock units																				Shares issued upon vesting of restricted stock units and performance stock units			227,729		2			—	—		(3,190)			—			—			(3,188)
Exercise of options to purchase common stock	Exercise of options to purchase common stock	13,118	—		—	—		157				—		—		157				Exercise of options to purchase common stock			19,804		—			—	—		274			—			—			274

Balance at November 28, 2020		95,818,871	$	958	98,234	$	(2,145)	$	1,077,538			$	107,880	$	(924)	$	1,183,307
Balance at November 27, 2021																				Balance at November 27, 2021			96,130,441		$	961		98,234	$	(2,145)	$	1,084,690		$	126,959		$	(858)		$	1,209,607

See accompanying notes to the unaudited condensed consolidated financial statements.

Table of Contents

Notes to Unaudited Condensed Consolidated Financial Statements

(Unaudited, dollars in thousands, except for share and per share data)

1. Nature of Operations and Principles of Consolidation

Description of Business

The Simply Good Foods Company (“Simply Good Foods” or the “Company”) is a consumer packaged food and beverage company that aims to lead the nutritious snacking movement with trusted brands that offer a variety of convenient, innovative, great-tasting, better-for-you snacks and meal ~~replacements.~~replacements, and other product offerings. The product portfolio the Company develops, markets and sells consists primarily of protein bars, ready-to-drink (“RTD”) shakes, sweet and salty snacks and confectionery products marketed under the Atkins®, Atkins Endulge®, Quest® and ~~Quest®~~Quest HeroTM brand names. Simply Good Foods is poised to expand its wellness platform through innovation and organic growth along with acquisition opportunities in the nutritional snacking space.

The Company’s nutritious snacking platform consists of brands that specialize in providing products for consumers that follow certain nutritional philosophies and health-and-wellness trends: Atkins® for those following a low-carb lifestyle and Quest® for consumers seeking a variety of protein-rich foods and beverages that also limit sugars and simple carbs. The Company distributes its products in major retail channels, primarily in North America, including grocery, club, and mass merchandise, as well as through e-commerce, convenience, specialty, and other channels. The Company’s portfolio of nutritious snacking brands gives it a strong platform with which to introduce new products, expand distribution, and attract new consumers to its products.

The common stock of Simply Good Foods is listed on the Nasdaq Capital Market under the symbol “SMPL.”

Unaudited Interim Condensed Consolidated Financial Statements

The unaudited interim condensed consolidated financial statements include the accounts of Simply Good Foods and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated. Unless the context otherwise requires, “we,” “us,” “our” and the “Company” refer to Simply Good Foods and its subsidiaries.

The Company maintains its accounting records on a 52/53-week fiscal year, ending on the last Saturday in August of each year.

The interim ~~condensed~~ consolidated financial statements and related notes of the Company and its subsidiaries are unaudited. The unaudited interim ~~condensed~~ consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”). The unaudited interim ~~condensed~~ consolidated financial statements reflect all adjustments and disclosures which are, in the Company’s opinion, necessary for a fair presentation of the results of operations, financial position and cash flows for the indicated periods. All such adjustments were of a normal and recurring nature unless otherwise disclosed. The year-end balance sheet data was derived from the audited financial statements and, in accordance with the instructions to Form 10-Q, certain information and footnote disclosures required by GAAP have been condensed or omitted. The results reported in these unaudited interim ~~condensed~~ consolidated financial statements are not necessarily indicative of the results that may be reported for the entire fiscal year and should be read in conjunction with the Company’s consolidated financial statements for the fiscal year ended August ~~28, 2021,~~27, 2022, included in the Company’s Annual Report on Form 10-K (“Annual Report”) filed with the SEC on October ~~26, 2021.~~21, 2022.

The ~~Company remains uncertain of the~~ ultimate effect ~~COVID-19~~the supply chain challenges, cost pressures, current high inflation environment, and the possible economic recession could have on ~~its~~consumer purchasing patterns and on the Company’s business ~~notwithstanding~~continues to be not fully known. Additionally, management is continuing to monitor the ~~distribution of several U.S. government approved vaccines,~~conflict in Ukraine, especially regarding the availability and cost of ~~booster inoculations~~raw materials that are produced in this region and Europe in general. Management is also monitoring the ~~easing of movement restrictions relative to the onset of COVID-19. This uncertainty stems from the potential~~situation in Eastern Europe for ~~among other things, (i) the rise of COVID-19 mutations that have resulted in increased rates of reported cases for which currently approved vaccines are or may not be as effective, (ii) unexpected~~its possible supply chain ~~disruptions, including disruptions resulting from labor shortages or other human capital challenges, (iii) changes to customer operations, (iv) a reversal in recently improving~~and consumer ~~purchasing and~~ consumption ~~behavior, and (v)~~effects on the ~~closure of or reduced access to customer establishments.~~Company’s business.

2. Summary of Significant Accounting Policies

Refer to Note 2, Summary of Significant Accounting Policies, to the consolidated financial statements included in the Annual Report for a description of significant accounting policies.

~~Table of Contents~~

Recently Issued and Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements Not Yet Adopted

In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional

Table of Contents

guidance for a limited period of time to ease the potential burden in accounting for reference rate reform on financial reporting. The amendments in this ASU are effective for all entities and can be applied to contract modifications due to rate reform and eligible existing and new hedging relationships entered into between March 12, 2020 and December 31, 2022. The amendments of this ASU should be applied on a prospective basis.

On January 21, 2022, the Company entered into a repricing amendment (the “2022 Repricing Amendment”) to its credit agreement with Barclays Bank PLC and other parties (as amended to date, the “Credit Agreement”), as described in Note 5, Long-Term Debt and Line of Credit. In addition to replacing the London Interbank Offered Rate (“LIBOR”) as the Credit Agreement’s reference rate with the Secured Overnight Financing Rate (“SOFR”), the 2022 Repricing Amendment contemporaneously modified other terms that changed, or had the potential to change, the amount or timing of contractual cash flows as contemplated by the guidance in ASU 2020-04. As such, the contract modifications related to the 2022 Repricing Amendment were outside of the scope of the optional guidance in ASU 2020-04. The Company will continue to monitor the effects of rate reform, if any, on any new or amended contracts through December 31, 2022. The Company does not anticipate the amendments in this ASU will be material to its ~~consolidated financial statements.~~

~~Recently Adopted Accounting Pronouncements~~

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which amends existing guidance related to the accounting for income taxes. This ASU was intended to simplify the accounting for income taxes by removing certain exceptions to the general principles of accounting for income taxes and to improve the consistent application of GAAP for other areas of accounting for income taxes by clarifying and amending existing guidance. The Company adopted this ASU as of the first day of fiscal year 2022. The adoption of this ASU did not have a material effect on the consolidated financial statements.

In October 2020, the FASB issued ASU 2020-10, Codification Improvements, which provided updates for technical corrections, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements across various areas of accounting within GAAP. The Company adopted this ASU as of the first day of fiscal year 2022 on a prospective basis. The adoption of this ASU did not have a material effect on the consolidated financial statements.

No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material effect on the Company’s consolidated financial statements.

3. Revenue Recognition

Revenue from transactions with external customers for each of the Company’s products would be impracticable to disclose and management does not view its business by product line. The following is a summary of revenue disaggregated by geographic area and ~~core~~ brands:


		Thirteen Weeks Ended				Thirteen Weeks Ended
(In thousands)	(In thousands)	November 27, 2021		November 28, 2020			(In thousands)	November 26, 2022		November 27, 2021
North America (1)	North America (1)						North America (1)
Atkins	Atkins	$	133,794	$	122,761		Atkins	$	131,745	$	133,794
Quest ~~(2)~~	Quest ~~(2)~~	138,294		95,769			Quest ~~(2)~~	161,472		138,294
Total North America	Total North America	272,088		218,530			Total North America	293,217		272,088
International	International	9,177		12,622			International	7,661		9,177
Total net sales	Total net sales	$	281,265	$	231,152		Total net sales	$	300,878	$	281,265
(1) The North America geographic area consists of net sales substantially related to the United States and there is no individual foreign country to which more than 10% of the Company’s net sales are attributed or that is otherwise deemed individually material.	(1) The North America geographic area consists of net sales substantially related to the United States and there is no individual foreign country to which more than 10% of the Company’s net sales are attributed or that is otherwise deemed individually material.						(1) The North America geographic area consists of net sales substantially related to the United States and there is no individual foreign country to which more than 10% of the Company’s net sales are attributed or that is otherwise deemed individually material.
(2) Quest net sales are primarily in North America.

Charges related to credit loss on accounts receivables from transactions with external customers were $(0.1) million for the thirteen weeks ended November 26, 2022, and were immaterial for the thirteen weeks ended November 27, ~~2021 and approximately $0.1 million for the thirteen weeks ended November 28, 2020.~~2021. As of November ~~27, 2021~~26, 2022 and August ~~28, 2021,~~27, 2022, the allowances for doubtful accounts related to these accounts receivable were $1.1 million and $1.2 million, respectively. Additionally, as of November 26, 2022, the Company had an expected credit loss reserve of $1.0 million on a $3.0 million note receivable related to the Company’s sale of its SimplyProtein® brand and ~~$1.1 million, respectively.~~related assets during its fiscal year 2021.

~~Table of Contents~~

4. Goodwill and Intangibles

As of November ~~27, 2021~~26, 2022 and August ~~28, 2021,~~27, 2022, Goodwill in the ~~Condensed~~ Consolidated Balance Sheets was $543.1 million. There were no impairment charges related to goodwill during the thirteen weeks ended November ~~27, 2021~~26, 2022 or since the inception of the Company.

Table of Contents

Intangible assets, net in the ~~Condensed~~ Consolidated Balance Sheets consists of the following:


					November 27, 2021										November 26, 2022
(In thousands)	(In thousands)	Useful life			Gross carrying amount		Accumulated amortization		Net carrying amount		(In thousands)	Useful life			Gross carrying amount		Accumulated amortization		Net carrying amount
Intangible assets with indefinite life:	Intangible assets with indefinite life:										Intangible assets with indefinite life:
Brands and trademarks	Brands and trademarks	Indefinite life			$	974,000	$	—	$	974,000	Brands and trademarks	Indefinite life			$	974,000	$	—	$	974,000
Intangible assets with finite lives:	Intangible assets with finite lives:										Intangible assets with finite lives:
Customer relationships	Customer relationships	15 years			174,000		33,003		140,997		Customer relationships	15 years			174,000		44,603		129,397
Licensing agreements	Licensing agreements	13 years			22,000		7,144		14,856		Licensing agreements	13 years			22,000		9,060		12,940
Proprietary recipes and formulas	Proprietary recipes and formulas	7 years			7,000		4,381		2,619		Proprietary recipes and formulas	7 years			7,000		5,381		1,619
Software and website development costs	Software and website development costs	3	-	5 years	5,863		3,267		2,596		Software and website development costs	3	-	5 years	5,863		4,525		1,338
Intangible assets in progress											Intangible assets in progress	3	-	5 years	53		—		53
															$	1,182,916	$	63,569	$	1,119,347
					$	1,182,863	$	47,795	$	1,135,068


					August 28, 2021										August 27, 2022
(In thousands)	(In thousands)	Useful life			Gross carrying amount		Accumulated amortization		Net carrying amount		(In thousands)	Useful life			Gross carrying amount		Accumulated amortization		Net carrying amount
Intangible assets with indefinite life:	Intangible assets with indefinite life:										Intangible assets with indefinite life:
Brands and trademarks	Brands and trademarks	Indefinite life			$	974,000	$	—	$	974,000	Brands and trademarks	Indefinite life			$	974,000	$	—	$	974,000
Intangible assets with finite lives:	Intangible assets with finite lives:										Intangible assets with finite lives:
Customer relationships	Customer relationships	15 years			174,000		30,103		143,897		Customer relationships	15 years			174,000		41,703		132,297
Licensing agreements	Licensing agreements	13 years			22,000		6,664		15,336		Licensing agreements	13 years			22,000		8,581		13,419
Proprietary recipes and formulas	Proprietary recipes and formulas	7 years			7,000		4,131		2,869		Proprietary recipes and formulas	7 years			7,000		5,131		1,869
Software and website development costs	Software and website development costs	3	-	5 years	5,560		2,924		2,636		Software and website development costs	3	-	5 years	5,863		4,190		1,673
Intangible assets in progress		3	-	5 years	303		—		303
					$	1,182,863	$	43,822	$	1,139,041
															$	1,182,863	$	59,605	$	1,123,258

Changes in Intangible assets, net during the thirteen weeks ended November ~~27, 2021~~26, 2022 were primarily related to recurring amortization expense. Amortization expense related to intangible assets was ~~$4.0~~$3.9 million and ~~$3.9~~$4.0 million for the thirteen weeks ended November ~~27, 2021~~26, 2022 and November ~~28, 2020,~~27, 2021, respectively. There were no impairment charges related to intangible assets during the thirteen weeks ended November ~~27, 2021~~26, 2022 and November ~~28, 2020.~~

27, 2021.

Estimated future amortization for each of the next five fiscal years and thereafter is as follows:


(In thousands)	(In thousands)	Amortization		(In thousands)	Amortization
Remainder of 2022		$	11,867
2023		15,602
Remainder of 2023				Remainder of 2023	$	11,703
2024	2024	14,917		2024	14,976
2025	2025	13,517		2025	13,542
2026	2026	13,517		2026	13,517
2027 and thereafter		91,648
2027				2027	13,517
2028 and thereafter				2028 and thereafter	78,039
Total	Total	$	161,068	Total	$	145,294

5. Long-Term Debt and Line of Credit

On July 7, 2017, the Company entered into a credit agreement with Barclays Bank PLC and other parties (as amended to date, the “Credit Agreement”). The Credit Agreement at that time provided for (i) a term facility of $200.0 million (“Term Facility”) with a seven-

~~Table of Contents~~

~~year~~-year maturity and (ii) a revolving credit facility of up to $75.0 million (the “Revolving Credit Facility”) with a five-year maturity. Substantially concurrent with the consummation of the business combination which formed the Company between Conyers Park Acquisition Corp. and NCP-ATK Holdings, Inc. on July 7, 2017, the full $200.0 million of the Term Facility (the “Term Loan”) was drawn.

Table of Contents

Effective as of December 16, 2021, the Company entered into a third amendment (the “Extension Amendment”) to the Credit Agreement. The Extension Amendment provided for an extension of the stated maturity date of the Revolving Commitments and Revolving Loans (each as defined in the Credit Agreement) from July 7, 2022 to the earlier of (i) 91 days prior to the then-effective maturity date of the Initial Term Loans and (ii) December 16, 2026.

On January 21, 2022, the Company entered into the “2022 Repricing Amendment” to the Credit Agreement. The 2022 Repricing Amendment, among other things, (i) reduced the interest rate per annum applicable to the Initial Term Loans outstanding under the Credit Agreement immediately prior to the effective date of the 2022 Repricing Amendment, (ii) reset the prepayment premium for the existing Initial Term Loans to apply to Repricing Transactions (as defined in the Credit Agreement) that occur within six months after the effective date of the 2022 Repricing Amendment, and (iii) implemented SOFR and related replacement provisions for LIBOR.

Effective as of the 2022 Repricing Amendment dated January 21, 2022, the interest rate per annum is based on ~~either (i) a~~either:

i.A base rate equaling the higher of (a) the “prime rate,” (b) the federal funds effective rate plus 0.50%, or (c) the ~~Euro-currency rate~~Adjusted Term SOFR Rate (as defined in the Credit Agreement) applicable for an interest period of one month plus 1.00% plus (x) ~~3.00%~~2.25% margin for the Term Loan or (y) 2.00% margin for the Revolving Credit ~~Facility,~~Facility; or ~~(ii) London Interbank Offered Rate (“LIBOR”) adjusted~~

ii.SOFR plus a credit spread adjustment equal to 0.10% for ~~statutory reserve requirements~~one-month SOFR, 0.15% for up to three-month SOFR and 0.25% for up to six-month SOFR, subject to a floor of 0.50%, plus (x) ~~4.00%~~3.25% margin for the Term Loan ~~subject to a floor of 1.00%~~ or (y) 3.00% margin for the Revolving Credit Facility.

The Simply Good Foods Company is not a borrower under the Credit Agreement and has not provided a guarantee of the Credit Agreement. Simply Good Foods USA, Inc., is the administrative borrower and certain other subsidiary holding companies are co-borrowers under the Credit Agreement. Each of the Company’s domestic subsidiaries that is not a named borrower under the Credit Agreement has provided a guarantee on a secured basis. As security for the payment or performance of the debt under the Credit Agreement, the borrowers and the guarantors have pledged certain equity interests in their respective subsidiaries and granted the lenders a security interest in substantially all of their domestic assets. All guarantors other than Quest Nutrition, LLC are holding companies with no assets other than their investments in their respective subsidiaries.

On March 16, 2018 (the “Amendment Date”), the Company entered into an amendment (the “Repricing Amendment”) to the Credit Agreement. As a result of the Repricing Amendment, the interest rate on the Term Loan was reduced and, as of the Amendment Date, such loans had an interest rate equal to, at the Company’s option, either LIBOR plus an applicable margin of 3.50%, or a base rate plus an applicable margin of 2.50%. The Repricing Amendment did not change the interest rate on the Revolving Credit Facility. The Revolving Credit Facility continued to bear interest based upon the Company’s consolidated net leverage ratio as of the last financial statements delivered to the administrative agent. No additional debt was incurred or any proceeds received by the Company in connection with the Repricing Amendment. The incremental fees paid to the administrative agent are reflected as additional debt discount and are amortized over the terms of the long-term financing agreements using the effective-interest method.

On November 7, 2019, the Company entered into a second amendment (the “Incremental Facility Amendment”) to the Credit Agreement to increase the principal borrowed on the Term Facility by $460.0 million. The Term Facility together with the incremental borrowing make up the Initial Term Loans (as defined in the Incremental Facility Amendment) and as of the Amendment No. 2 Effective Date (as defined in the Incremental Facility Amendment), the Initial Term Loans bear interest at a rate equal to, at the Company’s option, either LIBOR plus an applicable margin of 3.75%, or a base rate plus an applicable margin of 2.75%. The Incremental Facility Amendment was executed to partially finance the acquisition of Quest Nutrition, LLC on November 7, 2019. No amounts under the Term Facility were repaid as a result of the execution of the Incremental Facility Amendment.

Effective as of December 16, 2021, the Company entered into a third amendment (the “Extension Amendment”) to the Credit Agreement. The Extension Amendment provides for an extension of the stated maturity date of the Revolving Commitments and Revolving Loans (each as defined in the Credit Agreement) from July 7, 2022 to the earlier of (i) 91 days prior to the maturity date of the Initial Term Loans on July 7, 2024 and (ii) December 16, 2026.

The Credit Agreement contains certain financial and other covenants that limit the Company’s ability to, among other things, incur and/or undertake asset sales and other dispositions, liens, indebtedness, certain acquisitions and investments, consolidations, mergers, reorganizations and other fundamental changes, payment of dividends and other distributions to equity and warrant holders, and prepayments of material subordinated debt, in each case, subject to customary exceptions materially consistent with credit facilities of such type and size. The Revolving Credit Facility has a maximum total net leverage ratio equal to or less than 6.00:1.00 contingent on credit extensions in excess of 30% of the total amount of commitments available under the Revolving Credit Facility. Any failure to comply with the restrictions of the credit facilities may result in an event of default. The Company was in compliance with all financial covenants as of November ~~27, 2021~~26, 2022 and August ~~28, 2021,~~27, 2022, respectively.

Long-term debt consists of the following:


(In thousands)	(In thousands)	November 27, 2021		August 28, 2021		(In thousands)	November 26, 2022		August 27, 2022
Term Facility (effective rate of 4.8% at November 27, 2021)		431,500		456,500
Term Facility (effective rate of 7.7% at November 26, 2022)						Term Facility (effective rate of 7.7% at November 26, 2022)	$	400,000	$	406,500

Finance lease liabilities (effective rate of 5.6% at November 27, 2021)		620		690
Finance lease liabilities (effective rate of 5.6% at November 26, 2022)						Finance lease liabilities (effective rate of 5.6% at November 26, 2022)	333		406
Less: Deferred financing fees	Less: Deferred financing fees	4,814		5,636		Less: Deferred financing fees	3,089		3,620
Total debt	Total debt	427,306		451,554		Total debt	397,244		403,286

Less: Current finance lease liabilities	Less: Current finance lease liabilities	289		285		Less: Current finance lease liabilities	250		264
Long-term debt, net of deferred financing fees	Long-term debt, net of deferred financing fees	$	427,017	$	451,269	Long-term debt, net of deferred financing fees	$	396,994	$	403,022

The Company is not required to make principal payments on the Term Facility over the twelve months following the period ended November ~~27, 2021.~~26, 2022. The outstanding balance of the Term Facility is due upon its maturity in July 2024.

~~Table of Contents~~

As of November ~~27, 2021,~~26, 2022, the Company had letters of credit in the amount of $3.5 million outstanding. These letters of credit offset against the $75.0 million availability of the Revolving Credit Facility and exist to support three of the Company’s leased buildings and insurance programs relating to workers’ compensation. No amounts were drawn against these letters of credit at November ~~27, 2021.~~26, 2022.

Table of Contents

The Company utilizes market approaches to estimate the fair value of certain outstanding borrowings by discounting anticipated future cash flows derived from the contractual terms of the obligations and observable market interest and foreign exchange rates. The Company carries debt at historical cost and discloses fair value. As of November ~~27, 2021~~26, 2022 and August ~~28, 2021,~~27, 2022, the book value of the Company’s debt approximated fair value. The estimated fair value of the Term Loan is valued based on observable inputs and classified as Level 2 in the fair value hierarchy.

6. Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measurements, a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies, is used:

Level 1 – Valuations based on quoted prices for identical assets and liabilities in active markets.

Level 2 – Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.

Level 3 – Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.

Level 3 Measurements

~~The~~During the thirteen weeks ended November 27, 2021, the Company ~~has~~had outstanding liability-classified Private Warrants that ~~allow~~allowed holders to purchase 6,700,000 shares of the Company’s common stock. Such Private Warrants ~~are~~were held by Conyers Park Sponsor, LLC (“Conyers Park”), a related ~~party.~~party, and were exercised on a cashless basis on January 7, 2022 resulting in a net issuance of 4,830,761 shares of the Company’s common stock. As a result, there were no outstanding liability-classified Private Warrants as of November 26, 2022 and August 27, 2022. Refer to Note 10, Stockholders’ Equity, for additional details regarding the cashless exercise of the Private Warrants.

The Company ~~utilizes~~utilized the Black-Scholes model to estimate the fair value of the Private Warrants at each reporting date. The application of the Black-Scholes model utilizes significant assumptions, including volatility. Significant judgment is required in determining the expected volatility, historically the key assumption, of the Private Warrants. In order to determine the most accurate measure of this volatility, the Company measured expected volatility based on several inputs, including considering a peer group of publicly traded companies, the Company’s implied volatility based on traded options, the implied volatility of comparable warrants, and the implied volatility of any outstanding public warrants during the periods they were outstanding. As a result of the unobservable inputs that were used to determine the expected volatility of the Private Warrants, the fair value measurement of these warrants ~~reflects~~reflected a Level 3 measurement within the fair value measurement hierarchy.

There were 6,700,000 Private Warrants outstanding as of November 27, 2021 and November 28, 2020. The table below summarizes the inputs used to calculate the fair value of the warrant liability at each of the following reporting dates:

November 27, 2021 November 28, 2020
Exercise Price $ 11.50 $ 11.50
Stock Price $ 37.93 $ 22.36
Dividend Yield — % — %
Expected Term (in Years) 0.61 1.60
Risk-Free Interest Rate 0.15 % 0.14 %
Expected Volatility 27.34 % 25.60 %
Per Share Value of Warrants $ 26.44 $ 10.92

The periodic remeasurement of the warrant liability ishas been reflected in ~~(Loss) gain~~Loss in fair value change of warrant liability within the ~~Condensed~~ Consolidated Statements of Operations and Comprehensive Income. The ~~adjustments~~adjustment for the thirteen weeks ended November 27, 2021 ~~and November 28, 2020 were~~was a loss of $17.3 million and a gain of $20.5 million, respectively. The adjustments resulted in a total warrant liability at November 27, 2021 and November 28, 2020 of $177.2 million and $73.2 million, respectively.million.

7. Income Taxes

The tax expense and the effective tax rate resulting from operations were as follows:


		Thirteen Weeks Ended							Thirteen Weeks Ended
(In thousands)	(In thousands)	November 27, 2021			November 28, 2020			(In thousands)	November 26, 2022			November 27, 2021
Income before income taxes	Income before income taxes	$	33,975		$	51,327		Income before income taxes	$	45,556		$	33,975
Income tax expense	Income tax expense	$	12,823		$	8,374		Income tax expense	$	9,696		$	12,823
Effective tax rate	Effective tax rate	37.7		%	16.3		%	Effective tax rate	21.3		%	37.7		%

The effective tax rate for the thirteen weeks ended November ~~27, 2021~~26, 2022 was ~~21.4% greater~~16.4% less than the effective tax rate for the thirteen weeks ended November ~~28, 2020,~~27, 2021, which was primarily driven by the non-cash change in the fair value of the warrant liability in the prior fiscal period and other permanent differences.

Table of Contents

8. Leases

The components of lease expense were as follows:

Thirteen Weeks Ended
(In thousands) Statements of Operations Caption November 27, 2021 November 28, 2020
Operating lease cost:
Lease cost Cost of goods sold and General and administrative $ 2,255 $ 1,498
Variable lease cost (1)
Cost of goods sold and General and administrative 653 398
Total operating lease cost 2,908 1,896
Finance lease cost:
Amortization of right-of-use assets Cost of goods sold 68 68
Interest on lease liabilities Interest expense 9 13
Total finance lease cost 77 81
Total lease cost $ 2,985 $ 1,977

~~(1)~~ ~~Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.~~


		Thirteen Weeks Ended
(In thousands)	Statements of Operations Caption	November 26, 2022		November 27, 2021
Operating lease cost:
Lease cost	Cost of goods sold and General and administrative	$	2,252	$	2,255
Variable lease cost (1)	Cost of goods sold and General and administrative	738		653
Total operating lease cost		2,990		2,908


Finance lease cost:
Amortization of right-of-use assets	Cost of goods sold	68		68
Interest on lease liabilities	Interest expense	5		9
Total finance lease cost		73		77

Total lease cost		$	3,063	$	2,985
(1) Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.

In conjunction with the Company’s restructuring activities as discussed in Note 13, Restructuring and Related Charges, the Company recorded an immaterial gain on lease termination related to its lease in the Netherlands in the thirteen weeks ended November 27, 2021 and a $0.4 million impairment charge related to its operating lease right-of-use asset for its lease in Toronto, Ontario in the thirteen weeks ended November 28, 2020. The effect of these restructuring activities has been included within ~~General and administrative~~ ~~on the Condensed Consolidated Statements of Operations and Comprehensive Income. Refer to Note 13, Restructuring and Related Charges, for additional information regarding restructuring activities.~~

~~Table of Contents~~

The right-of-use assets and corresponding liabilities related to both operating and finance leases are as follows:


(In thousands)	(In thousands)	Balance Sheets Caption	November 27, 2021		August 28, 2021		(In thousands)	Balance Sheets Caption	November 26, 2022		August 27, 2022
Assets	Assets						Assets
Operating lease right-of-use assets	Operating lease right-of-use assets	Other long-term assets	$	50,116	$	46,197	Operating lease right-of-use assets	Other long-term assets	$	44,800	$	46,460
Finance lease right-of-use assets	Finance lease right-of-use assets	Property and equipment, net	571		640		Finance lease right-of-use assets	Property and equipment, net	299		367
Total lease assets	Total lease assets		$	50,687	$	46,837	Total lease assets		$	45,099	$	46,827

Liabilities	Liabilities						Liabilities
Current:	Current:						Current:
Operating lease liabilities	Operating lease liabilities	Accrued expenses and other current liabilities	$	4,774	$	3,788	Operating lease liabilities	Accrued expenses and other current liabilities	$	7,035	$	6,249
Finance lease liabilities	Finance lease liabilities	Current maturities of long-term debt	289		285		Finance lease liabilities	Current maturities of long-term debt	250		264
Long-term:	Long-term:						Long-term:
Operating lease liabilities	Operating lease liabilities	Other long-term liabilities	48,297		44,892		Operating lease liabilities	Other long-term liabilities	42,672		44,482
Finance lease liabilities	Finance lease liabilities	Long-term debt, less current maturities	331		405		Finance lease liabilities	Long-term debt, less current maturities	83		142
Total lease liabilities	Total lease liabilities		$	53,691	$	49,370	Total lease liabilities		$	50,040	$	51,137

Future maturities of lease liabilities as of November ~~27, 2021~~26, 2022 were as follows:

(In thousands) Operating Leases Finance Leases
Fiscal year ending:
Remainder of 2022 $ 5,490 $ 235
2023 8,349 278
2024 9,212 145
2025 8,462 —
2026 6,655 —
Thereafter 26,063 —
Total lease payments 64,231 658
Less: Interest (11,160) (38)
Present value of lease liabilities $ 53,071 $ 620


(In thousands)	Operating Leases		Finance Leases
Fiscal year ending:
Remainder of 2023	6,835		200
2024	9,424		145
2025	8,680		—
2026	6,880		—
2027	7,036		—
Thereafter	19,848		—
Total lease payments	58,703		345
Less: Interest	(8,996)		(12)
Present value of lease liabilities	$	49,707	$	333

Table of Contents

The weighted-average remaining lease terms and weighted-average discount rates for operating and finance leases were as follows:


		November 27, 2021		August 28, 2021			November 26, 2022		August 27, 2022
Weighted-average remaining lease term (in years)	Weighted-average remaining lease term (in years)					Weighted-average remaining lease term (in years)
Operating leases	Operating leases	7.83		8.38		Operating leases	7.09		7.27
Finance leases	Finance leases	2.20		2.44		Finance leases	1.30		1.51
Weighted-average discount rate	Weighted-average discount rate					Weighted-average discount rate
Operating leases	Operating leases	4.8	%	4.9	%	Operating leases	4.7	%	4.7	%
Finance leases	Finance leases	5.6	%	5.6	%	Finance leases	5.6	%	5.6	%

Supplemental and other information related to leases was as follows:

Thirteen Weeks Ended
(In thousands) November 27, 2021 November 28, 2020
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases $ 2,054 $ 1,811
Operating cash flows from finance leases $ 148 $ 7
Financing cash flows from finance leases $ 78 $ 78


	Thirteen Weeks Ended
(In thousands)	November 26, 2022		November 27, 2021
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	2,040	$	2,054
Operating cash flows from finance leases	$	131	$	148
Financing cash flows from finance leases	$	78	$	78

~~Table of Contents~~

9. Commitments and Contingencies

Litigation

The Company is a party to certain litigation and claims that are considered normal to the operations of the business. From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of business. The Company is not presently a party to any litigation that it believes to be material, and the Company is not aware of any pending or threatened litigation against it that its management believes could have a material adverse effect on its business, operating results, financial condition or cash flows.

~~As of November 27, 2021 and August 28, 2021, the Company had $0.7 million reserved for potential settlements.~~

Other

The Company has entered into endorsement contracts with certain celebrity figures and social media influencers to promote and endorse the Atkins and Quest brands and product lines. These contracts contain endorsement fees, which are expensed ratably over the life of the contract, and performance fees, that are recognized at the time of achievement. Based on the terms of the contracts in place and achievement of performance conditions as of November ~~27, 2021,~~26, 2022, the Company will be required to make payments of ~~$2.1~~$3.4 million over the next year.

10. Stockholders’ Equity

~~Warrants to Purchase Common Stock~~

As of November 27, 2021, the Company has outstanding liability-classified Private Warrants that allow holders to purchase 6,700,000 shares of the Company’s common stock. Such Private Warrants are held by Conyers Park Sponsor, LLC, a related party. Each whole warrant entitles the holder to purchase one share of the Company’s common stock at a price of $11.50 per share. The warrants expire on July 7, 2022 or earlier upon redemption or liquidation, as applicable.

As discussed in Note 6, Fair Value of Financial Instruments, the liability-classified warrants are remeasured on a recurring basis, primarily based on observable market data while the related theoretical private warrant volatility assumption within the Black-Scholes model represents a Level 3 measurement within the fair value measurement hierarchy. The periodic remeasurement of the warrant liability is reflected in ~~(Loss) gain in fair value change of warrant liability~~ ~~within the Condensed Consolidated Statements of Operations and Comprehensive Income.~~

Stock Repurchase Program

OnThe Company adopted a $50.0 million stock repurchase program on November 13, ~~2018,~~2018. On April 13, 2022, and October 21, 2022, the Company announced that its Board of Directors had ~~adopted a~~approved the addition of $50.0 million and $50.0 million, respectively, to its stock repurchase ~~program.~~program, resulting in authorized stock repurchases of up to an aggregate of $150.0 million. Under the stock repurchase program, the Company may repurchase shares from time to time in the open market or in privately negotiated transactions. The stock repurchase program does not obligate the Company to acquire any specific number of shares or acquire shares over any specific period of time. The stock repurchase program may be suspended or discontinued at any time by the Company and does not have an expiration date.

During the thirteen weeks ended November ~~27, 2021 and November 28, 2020,~~26, 2022, the Company repurchased 546,346 shares of common stock at an average share price of $30.11 per share. The Company did not repurchase any shares of common ~~stock.~~stock during the thirteen weeks ended November 27, 2021. As of November ~~27, 2021,~~26, 2022, approximately ~~$47.9~~$71.5 million remained available under the stock repurchase program.

Table of Contents

Warrants to Purchase Common Stock

During the thirteen weeks ended November 27, 2021, the Company had outstanding liability-classified Private Warrants that allowed holders to purchase 6,700,000 shares of the Company’s common stock. Such Private Warrants were held by Conyers Park, a related party. Each whole warrant entitled the holder to purchase one share of the Company’s common stock at a price of $11.50 per share. On January 7, 2022, Conyers Park elected to exercise the Private Warrants on a cashless basis, resulting in a net issuance of 4,830,761 shares of the Company’s common stock. As a result of the cashless exercise on January 7, 2022, there were no outstanding liability-classified Private Warrants as of as of November 26, 2022 and August 27, 2022.

As discussed in Note 6, Fair Value of Financial Instruments, the liability-classified warrants were remeasured on a recurring basis, primarily based on observable market data while the related theoretical private warrant volatility assumption within the Black-Scholes model represents a Level 3 measurement within the fair value measurement hierarchy. The periodic fair value remeasurements of the warrant liability have been reflected in Loss in fair value change of warrant liability within the Consolidated Statements of Operations and Comprehensive Income.

11. Earnings Per Share

Basic earnings or loss per share is based on the weighted average number of common shares issued and outstanding. In computing diluted earnings per share, basic earnings per share is adjusted for the assumed issuance of all potentially dilutive ~~securities.~~securities, including the Company’s employee stock options, non-vested stock units, and Private Warrants for the periods during which they were outstanding. During periods when the effect of the outstanding Private Warrants was dilutive, the Company assumed share settlement of the instruments as of the beginning of the reporting period and adjusted the numerator to remove the change in fair value of the warrant liability and adjusted the denominator to include the dilutive shares, calculated using the treasury stock method. During periods when the effect of the outstanding Private Warrants was anti-dilutive, the share settlement was excluded.

In periods in which the Company has a net loss, diluted ~~earnings~~loss per share is based on the weighted average number of common shares issued and outstanding as the effect of including common stock equivalents outstanding would be anti-dilutive.

As of November 27, 2021, the Company has outstanding liability-classified Private Warrants to purchase 6,700,000 shares of the Company’s common stock. During periods when the effect is dilutive, the Company assumes share settlement of the instruments as of the beginning of the reporting period and adjusts the numerator to remove the change in fair value of the warrant liability and adjusts the denominator to include the dilutive shares, calculated using the treasury stock method. During periods when the impact is anti-dilutive, the share settlement is excluded.

~~Table of Contents~~

The following table reconciles the numerators and denominators used in the computations of both basic and diluted earnings per share:


		Thirteen Weeks Ended				Thirteen Weeks Ended
(In thousands, except per share data)	(In thousands, except per share data)	November 27, 2021		November 28, 2020			(In thousands, except per share data)	November 26, 2022		November 27, 2021
Basic earnings per share computation:	Basic earnings per share computation:						Basic earnings per share computation:
Numerator:	Numerator:						Numerator:
Net income available to common stockholders	Net income available to common stockholders	$	21,152	$	42,953		Net income available to common stockholders	$	35,860	$	21,152
Denominator:	Denominator:						Denominator:
Weighted average common shares outstanding - basic	Weighted average common shares outstanding - basic	95,856,845		95,538,111			Weighted average common shares outstanding - basic	99,200,557		95,856,845
Basic earnings per share from net income	Basic earnings per share from net income	$	0.22	$	0.45		Basic earnings per share from net income	$	0.36	$	0.22

Diluted earnings per share computation:	Diluted earnings per share computation:						Diluted earnings per share computation:
Numerator:	Numerator:						Numerator:
Net income available for common stockholders	Net income available for common stockholders	$	21,152	$	42,953		Net income available for common stockholders	$	35,860	$	21,152
Gain in fair value change of warrant liability		—		(20,453)

Numerator for diluted earnings per share	Numerator for diluted earnings per share	$	21,152	$	22,500		Numerator for diluted earnings per share	$	35,860	$	21,152
Denominator:	Denominator:						Denominator:
Weighted average common shares outstanding - basic	Weighted average common shares outstanding - basic	95,856,845		95,538,111			Weighted average common shares outstanding - basic	99,200,557		95,856,845

Private Warrants		—		3,216,252
Employee stock options	Employee stock options	1,652,577		899,375			Employee stock options	1,299,543		1,652,577
Non-vested shares		352,151		109,381
Non-vested stock units							Non-vested stock units	222,936		352,151
Weighted average common shares - diluted	Weighted average common shares - diluted	97,861,573		99,763,119			Weighted average common shares - diluted	100,723,036		97,861,573
Diluted earnings per share from net income	Diluted earnings per share from net income	$	0.22	$	0.23		Diluted earnings per share from net income	$	0.36	$	0.22

~~The diluted~~Diluted earnings per share ~~calculation~~calculations for the thirteen weeks ended November 26, 2022 and November 27, 2021 excluded 0.4 million shares and 0.2 million shares of common stock issuable upon exercise of stock options, respectively, that would have been anti-dilutive.

Table of Contents

Diluted earnings per share calculations for the thirteen weeks ended November 26, 2022 and November 27, 2021 excluded 0.1 million non-vested stock units and an immaterial number of non-vested stock units, respectively, that would have been anti-dilutive.

Diluted earnings per share calculations for the thirteen weeks ended November 27, 2021 excluded 4.6 million shares issuable upon exercise of Private Warrants that would have been anti-dilutive. Diluted earnings per share calculations for the thirteen weeks ended November 27, 2021 and November 28, 2020 excluded 0.2 million and 0.7 million shares of common stock issuable upon exercise of stock options, respectively, that would have been anti-dilutive. An immaterial number of non-vested restricted stock units that would have been anti-dilutive were excluded from diluted earnings per share calculations for the thirteen weeks ended November 27, 2021 and November 28, 2020.

12. Omnibus Incentive Plan

Stock-based compensation includes stock options, restricted stock units, performance stock unit awards and stock appreciation rights, which are awarded to employees, directors, and consultants of the Company. Stock-based compensation expense for equity-classified awards is recognized on a straight-line basis over the requisite service period of the award based on their grant date fair value. Stock-based compensation expense is included within General and administrative expense, which is the same financial statement caption where the recipient’s other compensation is reported.

The Company recorded stock-based compensation expense of ~~$2.6~~$3.3 million and ~~$1.1~~$2.6 million in the thirteen weeks ended November ~~27, 2021~~26, 2022 and November ~~28, 2020,~~27, 2021, respectively.

~~Table of Contents~~

Stock Options

The following table summarizes stock option activity for the thirteen weeks ended November ~~27, 2021:~~26, 2022:

Shares underlying options Weighted average
exercise price Weighted average remaining contractual life (years)
Outstanding as of August 28, 2021 2,993,163 $ 16.31
Granted 138,479 40.88
Exercised (19,804) 13.83
Forfeited (2,300) 19.89
Outstanding as of November 27, 2021 3,109,538 $ 17.42 6.73
Vested and expected to vest as of November 27, 2021 3,109,538 $ 17.42 6.73
Exercisable as of November 27, 2021 2,494,944 $ 14.13 6.10


	Shares underlying options	Weighted average exercise price		Weighted average remaining contractual life (years)
Outstanding as of August 27, 2022	2,776,551	$	18.04	6.10
Granted	135,001	38.61
Exercised	(314,431)	14.51
Forfeited	—	—
Outstanding as of November 26, 2022	2,597,121	$	19.54	6.09
Vested and expected to vest as of November 26, 2022	2,597,121	$	19.54	6.09
Exercisable as of November 26, 2022	2,064,196	$	15.62	5.42

As of November ~~27, 2021,~~26, 2022, the Company had ~~$6.5~~$6.0 million of total unrecognized compensation cost related to stock ~~option plans~~options that will be recognized over a weighted average period of ~~2.3~~1.9 years. During the thirteen weeks ended November ~~27, 2021~~26, 2022 and November ~~28, 2020,~~27, 2021, the Company received ~~$0.3~~$4.6 million and ~~$0.2~~$0.3 million in cash from stock option exercises, respectively.

Restricted Stock Units

The following table summarizes restricted stock unit activity for the thirteen weeks ended November ~~27, 2021:~~26, 2022:


		Units	Weighted average grant-date fair value			Units	Weighted average grant-date fair value
Non-vested as of August 28, 2021		496,334	$	24.56
Non-vested as of August 27, 2022					Non-vested as of August 27, 2022	453,003	$	30.68
Granted	Granted	129,423	39.54		Granted	245,591	37.18
Vested	Vested	(139,459)	22.13		Vested	(167,979)	27.22
Forfeited	Forfeited	(10,675)	25.72		Forfeited	—	—
Non-vested as of November 27, 2021		475,623	$	29.34
Non-vested as of November 26, 2022					Non-vested as of November 26, 2022	530,615	$	34.78

As of November ~~27, 2021,~~26, 2022, the Company had ~~$12.1~~$15.7 million of total unrecognized compensation cost related to restricted stock units that will be recognized over a weighted average period of ~~2.0~~1.8 years.

Performance Stock Units

During the thirteen weeks ended November ~~27, 2021,~~26, 2022, the Board of Directors granted performance stock units under the Company’s equity compensation plan. Performance stock units vest in a range between 0% and 200% based upon certain performance criteria in a three-year period. Performance stock units were valued using a Monte Carlo simulation.

Table of Contents

The following table summarizes performance stock unit activity for the thirteen weeks ended November ~~27, 2021:~~26, 2022:


		Units	Weighted average grant-date fair value			Units	Weighted average grant-date fair value
Non-vested as of August 28, 2021		380,097	$	19.31
Non-vested as of August 27, 2022					Non-vested as of August 27, 2022	255,023	$	32.82
Granted	Granted	50,212	63.42		Granted	50,629	62.55
Vested	Vested	(166,688)	11.93		Vested	(72,452)	27.39
Forfeited	Forfeited	(6,350)	16.48		Forfeited	(20,338)	27.39
Non-vested as of November 27, 2021		257,271	$	32.77
Non-vested as of November 26, 2022					Non-vested as of November 26, 2022	212,862	$	42.25

As of November ~~27, 2021,~~26, 2022, the Company had ~~$5.7~~$6.0 million of total unrecognized compensation cost related to performance stock units that will be recognized over a weighted average period of ~~1.8~~1.7 years.

~~Table of Contents~~

Stock Appreciation Rights

Stock appreciation rights (“SARs”) permit the holder to participate in the appreciation of the Company’s common stock price and are awarded to non-employee consultants of the Company. The Company’s SARs settle in shares of its common stock once the applicable vesting criteria ~~has~~have been met. The SARs outstanding as of November 26, 2022 cliff vest ~~three~~two years from the date of grant and must be exercised within ~~ten~~five years.

The following table summarizes SARs activity for the thirteen weeks ended November ~~27, 2021:~~26, 2022:

Shares underlying SARs Weighted average
exercise price Weighted average remaining contractual life (years)
Outstanding as of August 28, 2021 150,000 $ 24.20
Granted — —
Exercised — —
Forfeited — —
Outstanding as of November 27, 2021 150,000 $ 24.20 7.93
Vested and expected to vest as of November 27, 2021 150,000 $ 24.20 7.93
Exercisable as of November 27, 2021 — $ — 0.00


	Shares underlying SARs	Weighted average exercise price
Outstanding as of August 27, 2022	150,000	$	24.20
Granted	150,000	37.67
Exercised	(150,000)	24.20
Forfeited	—	—
Outstanding as of November 26, 2022	150,000	$	37.67

AsThe SARs exercised in the thirteen weeks ended November 26, 2022 resulted in a net issuance of 38,850 shares of the Company’s common stock. The SARs granted in the thirteen weeks ended November ~~27, 2021,~~26, 2022 are liability-classified; therefore the ~~Company had $0.1 million~~related stock-based compensation expense is based on the vesting provisions and the fair value of ~~total unrecognized compensation cost related to its SARs that will be recognized over a weighted average period of 0.9 years.~~the awards.

13. Restructuring and Related Charges

In May 2020, the Company announced certain restructuring activities in conjunction with the implementation of the Company’s future-state organization design, which created a fully integrated organization with its completed acquisition of Quest Nutrition, LLC on November 7, 2019. The new organization design became effective on August 31, 2020. These restructuring plans primarily ~~include~~included workforce reductions, changes in management structure, and the relocation of business activities from one location to another.

The ~~one-time termination benefits and employee severance~~Company substantially completed its restructuring activities during the third quarter of fiscal 2022; therefore no restructuring or restructuring-related costs ~~to be~~were incurred in relation to these restructuring activities are accounted for in accordance with ASC Topic 420, Exit or Disposal Cost Obligations, and ASC Topic 712, Compensation - Nonretirement Postemployment Benefits, respectively. The Company recognizes a liability and the related expense for these restructuring costs when the liability is incurred and can be measured. Restructuring accruals are based upon management estimates at the time and can change depending upon changes in facts and circumstances subsequent to the date the original liability was recorded.

~~Changes to the restructuring liability during~~thirteen weeks ended November 26, 2022. In the thirteen weeks ended November 27, 2021, ~~were as follows:~~

(In thousands) Termination benefits and severance Other Restructuring liability
Balance as of August 28, 2021 $ 851 $ — $ 851
Charges 44 28 72
Cash payments (748) (28) (776)
Balance as of November 27, 2021 $ 147 $ — $ 147

~~In addition to the restructuring costs shown above,~~ the Company ~~recorded~~incurred an immaterial ~~gain on lease termination related to its lease in the Netherlands in the thirteen weeks ended November 27, 2021. As a result, the Company’s total~~amount of restructuring and restructuring-related costs incurred in the thirteen weeks ended November 27, 2021 were immaterial. The Company incurred a total of $2.5 million in restructuring and restructuring-related costs in the thirteen weeks ended November 28, 2020. The effect of these restructuring activities has been included within ~~General and administrative~~ ~~on the Condensed Consolidated Statements of Operations and Comprehensive Income.~~

costs. Since the announcement of the restructuring activities ~~were announced~~ in May 2020, the Company ~~has~~ incurred aggregate restructuring and restructuring-related costs of $9.9 million. ~~Overall, the Company expects to incur a total of approximately $10.1 million in restructuring and restructuring-related costs, which are to be paid through the second quarter of fiscal year 2022.~~

1817

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements. When used anywhere in this Report, the words “expect,” “believe,” “anticipate,” “estimate,” “intend,” “plan” and similar expressions are intended to identify forward-looking statements. These statements relate to future events or our future financial or operational performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. These statements include, but are not limited to, ~~the effect of the COVID-19 pandemic on our business, financial condition and results of operations,~~ our expectations regarding our supply chain, including but not limited to, raw materials and logistics costs, ~~and~~ the effect of price ~~increases.~~increases, inflationary pressure on us and our contract manufacturers, and the unforeseen business disruptions or other effects due to current global geopolitical tensions, including relating to Ukraine. We disclaim any undertaking to publicly update or revise any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is ~~based.~~based, except as required by applicable law. These statements reflect our current views with respect to future events and are based on assumptions subject to risks and uncertainties. Such risks and uncertainties include those related to our ability to sell our products.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended August ~~28, 2021~~27, 2022 (“Annual Report”) and our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this Report. In addition to historical information, the following discussion contains forward-looking statements, including, but not limited to, statements regarding the Company’s expectation for future performance, liquidity and capital resources that involve risks, uncertainties and assumptions that could cause actual results to differ materially from the Company’s expectations. The Company’s actual results may differ materially from those contained in or implied by any forward-looking statements. Factors that could cause such differences include those identified in Item 1A. “Risk Factors” of our Annual Report. The Company assumes no obligation to update any of these forward-looking statements.

Unless the context requires otherwise in this Report, the terms “we,” “us,” “our,” the “Company” and “Simply Good Foods” refer to The Simply Good Foods Company and its subsidiaries.

Overview

The Simply Good Foods Company is a consumer packaged food and beverage company that aims to lead the nutritious snacking movement with trusted brands that offer a variety of convenient, innovative, great-tasting, better-for-you snacks and meal ~~replacements.~~replacements, and other product offerings. The product portfolio we develop, market and sell consists primarily of protein bars, ready-to-drink (“RTD”) shakes, sweet and salty snacks and confectionery products marketed under the Atkins®, Atkins Endulge®, Quest® and ~~Quest®~~Quest HeroTM brand names. We believe Simply Good Foods is poised to expand its wellness platform through innovation and organic growth along with acquisition opportunities in the nutritional snacking space.

Our nutritious snacking platform consists of brands that specialize in providing products for consumers that follow certain nutritional philosophies and health-and-wellness trends: Atkins® for those following a low-carb lifestyle and Quest® for consumers seeking a variety of protein-rich foods and beverages that also limit sugars and simple carbs. We distribute our products in major retail channels, primarily in North America, including grocery, club, and mass merchandise, as well as through e-commerce, convenience, specialty, and other channels. Our portfolio of nutritious snacking brands gives us a strong platform with which to introduce new products, expand distribution, and attract new consumers to our products.

~~Effects of COVID-19~~Business Trends

~~For~~We continue to actively monitor the ~~thirteen weeks ended November 27, 2021, our business improved from~~impact of the end of fiscal year 2021, driven in part by the increasing normalization of consumer mobility and shopper traffic patterns in brick and mortar retailers versus prior periods that were pressured by COVID-19 movement restrictions. The improvement in consumer mobility and shopper traffic patterns however remains fragile and there continues to be uncertainty related to the sustainability and longevity of these trends. In addition, these positive trends could be negatively affected by an increasedynamic macroeconomic inflationary environment in the ~~number~~United States and ~~rate~~elsewhere, elevated levels of reported positive cases of COVID-19, especially resulting from new variants of the virus, along with any government actions to reimpose mobility restrictions. During fiscal year 2022, we expect our business performance will continue to be affected bysupply chain cost inflation, and the level of consumer mobility, which includes the rate at which consumers return to working outside the home. Current or future governmental policies may increase the risk of inflation and possible economic recession, which could further increase the costs of ingredients, packaging and finished goods for our business as well as negatively effect consumer behavior and demand for our products. Additionally, management is continuing to monitor the conflict in Ukraine, especially regarding the availability and cost of raw materials that are produced in this region and Europe in general. Management is also monitoring for signs of any expansion of economic or supply chain disruptions or broader supply chain inflationary costs resulting either directly or indirectly from the crisis in Eastern Europe.

During the thirteen weeks ended November 26, 2022, our business performance was affected by the corresponding unfavorable effects of higher raw material costs, higher co-manufacturing costs, higher freight and logistics costs, and supply chain challenges, including supply chain disruptions resulting from labor shortages and disruptions in ingredients, and we expect these inflationary cost pressures and supply chain challenges to continue for the remainder of fiscal year 2023.

Table of Contents

We ~~have actively engaged~~continue to proactively engage with ~~the various elements of our value chain, including~~ our retail customers, contract manufacturers, and logistics and transportation providers, to meet demand for our products and to remain informed of any challenges within our ~~value chain. Although~~business operations. Additionally, we instituted price increases effective in the first and fourth quarters of fiscal year 2022. Management believes these price increases and additional cost savings initiatives will partially offset the unfavorable effects of the supply chain cost pressures discussed above.

The ultimate effect the supply chain challenges, cost pressures, current high inflation environment, and the possible economic recession discussed above could have on consumer ~~consumption habits have become steadier, inventory levels remain variable.~~purchasing patterns and on our business continue to be not fully known.

Based on information available to us as of the date of this Report, we believe we will be able to deliver products at acceptable levels to ~~fulfil~~fulfill customer orders on a timely basis; therefore, we expect our products will continue to be available for purchase to meet consumer meal replacement and snacking needs

for the foreseeable future. We continue to monitor customer and consumer demand along with our supply chain and logistics capabilities and intend to adapt our plans as needed to continue to drive our business and meet our ~~obligations during the continuing and evolving COVID-19 situation.~~

We remain uncertain of the ultimate effect COVID-19 could have on our business notwithstanding the distribution of several U.S. government approved vaccines, the availability of booster inoculations and the easing of movement restrictions relative to the onset of COVID-19. This uncertainty stems from the potential for, among other things, (i) the rise of COVID-19 mutations that have resulted in increased rates of reported cases for which currently approved vaccines are or may not be as effective, (ii) unexpected supply chain disruptions, including disruptions resulting from labor shortages or other human capital challenges, (iii) changes to customer operations, (iv) a reversal in recently improving consumer purchasing and consumption behavior, and (v) the closure of or reduced access to customer establishments.

~~Restructuring and Related Charges~~

In May 2020, we announced certain restructuring activities in conjunction with the implementation of our future-state organization design, which created a fully integrated organization with our completed acquisition of Quest Nutrition, LLC on November 7, 2019. The new organization design became effective on August 31, 2020. These restructuring plans primarily include workforce reductions, changes in management structure, and the relocation of business activities from one location to another.

Total restructuring and restructuring-related costs incurred in the thirteen weeks ended November 27, 2021 were immaterial. We incurred a total of $2.5 million in restructuring and restructuring-related costs in the thirteen weeks ended November 28, 2020. The effect of these restructuring activities has been included within ~~General and administrative~~ on the Condensed Consolidated Statements of Operations and Comprehensive Income. Since the restructuring activities were announced in May 2020, we have incurred aggregate restructuring and restructuring-related costs of $9.9 million. Overall, we expect to incur a total of approximately $10.1 million in restructuring and restructuring-related costs, including the $9.9 million previously incurred, and the balance of which will be paid through the second quarter of fiscal year 2022. As of November 27, 2021, the outstanding restructuring liability was $0.1 million. Refer to Note 13, Restructuring and Related Charges, of our Notes to Unaudited Condensed Consolidated Financial Statements in this Report for additional information regarding restructuring activities.

~~SimplyProtein Sale~~

Effective September 24, 2020, we sold the assets exclusively related to our SimplyProtein® brand of products for approximately $8.8 million of consideration, including cash of $5.8 million and a note receivable for $3.0 million, to a newly formed entity led by the Company’s former Canadian-based management team who had been responsible for this brand prior to the sale transaction (the “SimplyProtein Sale”). In addition to purchasing these assets, the buyer assumed certain liabilities related to the SimplyProtein® brand’s business. There was no gain or loss recognized as a result of the SimplyProtein Sale. The transaction has enabled our management to focus its full time and resources on our core Atkins® and Quest® branded businesses and other strategic initiatives.

~~Supply Chain~~

We expect higher raw material and logistics costs in fiscal year 2022. As a result, we instituted a price increase effective in September 2021, the first month of our fiscal year 2022. Management believes the price increase and cost savings initiatives will enable us to continue to invest in projects that drive growth.

We have begun to see logistics challenges, which we believe have contributed to lower retail and e-commerce sales of our products due to out-of-stock situations, delayed recognition of sales and higher than historical inventory levels. In addition, we could experience additional lost sale opportunities at our retail and e-commerce customers if our products are not available for purchase as a result of disruptions in our supply chain relating to an inability to obtain ingredients or packaging, labor challenges at our logistics providers or our contract manufacturers, or if our customers experience delays in stocking our products.

obligations.

Key Financial Definitions

Net sales. Net sales consist primarily of product sales less the cost of promotional activities, slotting fees and other sales credits and adjustments, including product returns.

Cost of goods sold. Cost of goods sold consists primarily of the costs we pay to our contract manufacturing partners to produce the products sold. These costs include the purchase of raw ingredients, packaging, shipping and handling, warehousing, depreciation of warehouse equipment, and a tolling charge for the contract manufacturer. Cost of goods sold includes products provided at no charge as part of promotions and the non-food materials provided with customer orders.

Operating expenses. Operating expenses consist primarily of selling and marketing, general and administrative, and depreciation and amortization ~~and business transaction costs.~~expense. The following is a brief description of the components of operating expenses:

•Selling and marketing. Selling and marketing expenses comprise broker commissions, customer marketing, media and other marketing costs.

•General and administrative. General and administrative expenses comprise expenses associated with corporate and administrative functions that support our business, including employee compensation, stock-based compensation, professional services, integration costs, restructuring costs, insurance and other general corporate expenses.

•Depreciation and amortization. Depreciation and amortization costs consist of costs associated with the depreciation of fixed assets and capitalized leasehold improvements and amortization of intangible assets.

Results of Operations

~~Sales and earnings growth improved for both the Atkins® and Quest® brands during~~During the thirteen weeks ended November ~~27, 2021, driven by improving consumer mobility~~26, 2022, our net sales increased $19.6 million, or 7.0%, and ~~shopper trips~~our gross profit decreased $5.6 million, or 4.8%, compared to the thirteen weeks ended November ~~28, 2020, as well as increasing household penetration and innovation that continues to resonate with consumers. As a result of~~27, 2021. Net sales for the thirteen weeks ended November 26, 2022 were positively affected by the price increase effective in ~~September 2021 as well as favorable product form~~the fourth quarter of fiscal year 2022 and ~~retail channel mix, we were able to more than offset~~both the Atkins® and Quest® brands experienced sales growth driven by increased e-commerce sales volume. However, unfavorable effects of higher raw material ~~costs, logistics~~and co-manufacturing costs and supply chain challenges in the thirteen weeks ended November 26, 2022 resulted in decreased gross profit and gross profit margin as compared to the thirteen weeks ended November 27, ~~2021 and achieve gross margin expansion and earnings growth.~~2021. As previously discussed above in ~~“Supply Chain,~~“Business Trends,” we expect these inflationary cost pressures and supply chain challenges to continue ~~to expect to have higher raw material and logistics costs in~~for the remainder of fiscal year ~~2022 as compared to fiscal year 2021.~~2023.

In assessing the performance of our business, we consider a number of key performance indicators used by management and typically used by our competitors, including the non-GAAP measures EBITDA and Adjusted EBITDA. Because not all companies use identical calculations, ~~the~~this presentation of EBITDA and Adjusted EBITDA may not be comparable to other similarly titled measures of other companies. See “Reconciliation of EBITDA and Adjusted EBITDA” below for a reconciliation of EBITDA and Adjusted EBITDA to net income for each applicable period.

2119

Table of Contents

Comparison of Unaudited Results for the Thirteen Weeks Ended November ~~27, 2021~~26, 2022 and the Thirteen Weeks Ended November ~~28, 2020~~27, 2021

The following unaudited table presents, for the periods indicated, selected information from our ~~Condensed~~ Consolidated Statements of Operations and Comprehensive Income, including information presented as a percentage of net sales:


		Thirteen Weeks Ended				Thirteen Weeks Ended					Thirteen Weeks Ended				Thirteen Weeks Ended
(In thousands)	(In thousands)	November 27, 2021		% of Sales		November 28, 2020		% of Sales		(In thousands)	November 26, 2022		% of Net Sales		November 27, 2021		% of Net Sales
Net sales	Net sales	$	281,265	100.0	%	$	231,152	100.0	%	Net sales	$	300,878	100.0	%	$	281,265	100.0	%
Cost of goods sold	Cost of goods sold	164,710		58.6	%	137,111		59.3	%	Cost of goods sold	189,886		63.1	%	164,710		58.6	%
Gross profit	Gross profit	116,555		41.4	%	94,041		40.7	%	Gross profit	110,992		36.9	%	116,555		41.4	%

Operating expenses:	Operating expenses:									Operating expenses:
Selling and marketing	Selling and marketing	30,527		10.9	%	25,195		10.9	%	Selling and marketing	28,534		9.5	%	30,527		10.9	%
General and administrative	General and administrative	23,702		8.4	%	25,415		11.0	%	General and administrative	25,641		8.5	%	23,702		8.4	%
Depreciation and amortization	Depreciation and amortization	4,320		1.5	%	4,244		1.8	%	Depreciation and amortization	4,327		1.4	%	4,320		1.5	%

Total operating expenses	Total operating expenses	58,549		20.8	%	54,854		23.7	%	Total operating expenses	58,502		19.4	%	58,549		20.8	%

Income from operations	Income from operations	58,006		20.6	%	39,187		17.0	%	Income from operations	52,490		17.4	%	58,006		20.6	%

Other income (expense):	Other income (expense):									Other income (expense):
Interest income	Interest income	1		—	%	3		—	%	Interest income	7		—	%	1		—	%
Interest expense	Interest expense	(6,371)		(2.3)	%	(8,372)		(3.6)	%	Interest expense	(7,055)		(2.3)	%	(6,371)		(2.3)	%
(Loss) gain in fair value change of warrant liability		(17,317)		(6.2)	%	20,453		8.8	%
Loss in fair value change of warrant liability										Loss in fair value change of warrant liability	—		—	%	(17,317)		(6.2)	%

(Loss) gain on foreign currency transactions		(353)		(0.1)	%	9		—	%
Gain (loss) on foreign currency transactions										Gain (loss) on foreign currency transactions	108		—	%	(353)		(0.1)	%
Other income	Other income	9		—	%	47		—	%	Other income	6		—	%	9		—	%
Total other (expense) income		(24,031)		(8.5)	%	12,140		5.3	%
Total other expense										Total other expense	(6,934)		(2.3)	%	(24,031)		(8.5)	%

Income before income taxes	Income before income taxes	33,975		12.1	%	51,327		22.2	%	Income before income taxes	45,556		15.1	%	33,975		12.1	%
Income tax expense	Income tax expense	12,823		4.6	%	8,374		3.6	%	Income tax expense	9,696		3.2	%	12,823		4.6	%
Net income	Net income	$	21,152	7.5	%	$	42,953	18.6	%	Net income	$	35,860	11.9	%	$	21,152	7.5	%

Other financial data:	Other financial data:									Other financial data:
Adjusted EBITDA (1)	Adjusted EBITDA (1)	$	65,615	23.3	%	$	48,697	21.1	%	Adjusted EBITDA (1)	$	60,766	20.2	%	$	65,615	23.3	%
(1) Adjusted EBITDA is a non-GAAP financial metric. See “Reconciliation of EBITDA and Adjusted EBITDA” below for a reconciliation of net income to EBITDA and Adjusted EBITDA for each applicable period.	(1) Adjusted EBITDA is a non-GAAP financial metric. See “Reconciliation of EBITDA and Adjusted EBITDA” below for a reconciliation of net income to EBITDA and Adjusted EBITDA for each applicable period.									(1) Adjusted EBITDA is a non-GAAP financial metric. See “Reconciliation of EBITDA and Adjusted EBITDA” below for a reconciliation of net income to EBITDA and Adjusted EBITDA for each applicable period.

Net sales. Net sales of ~~$281.3~~$300.9 million represented an increase of ~~$50.1~~$19.6 million, or ~~21.7%~~7.0%, for the thirteen weeks ended November ~~27, 2021~~26, 2022 compared to the thirteen weeks ended November ~~28, 2020.~~27, 2021. The increase was primarily attributable to ~~retail~~the price increase effective in the fourth quarter of fiscal year 2022 and e-commerce sales volume ~~growth and e-commerce~~ growth for both the Atkins® and Quest® brands, which increased our North America net sales by ~~24.5%~~7.8% in the thirteen weeks ended November ~~27, 2021~~26, 2022 compared to the thirteen weeks ended November ~~28, 2020. Additionally, we instituted a price increase effective in September 2021, the first month of our fiscal year 2022.~~27, 2021. The increase in North America net sales was partially offset by a ~~27.3%~~16.5% decline in our international business ~~due to the European exit. The European exit represented~~and a ~~1.6%~~1.1% headwind to ~~total Company~~ net sales ~~growth.~~growth related to our shift from direct sales to licensing the Quest® frozen pizza business in the third quarter of fiscal year 2022.

Cost of goods sold. Cost of goods sold increased ~~$27.6~~$25.2 million, or ~~20.1%~~15.3%, for the thirteen weeks ended November ~~27, 2021~~26, 2022 compared to the thirteen weeks ended November ~~28, 2020.~~27, 2021. The cost of goods sold increase was driven by higher raw material, packaging, and co-manufacturing costs and supply chain challenges for the thirteen weeks ended November 26, 2022 as well as sales volume growth for both the Atkins® and Quest® brands, as discussed above. ~~Additionally, our cost of goods sold for the thirteen weeks ended November 27, 2021 was unfavorably affected by higher raw material costs, logistics costs, and supply chain challenges.~~ As previously discussed above in ~~“Supply Chain,~~“Business Trends,” we expect these inflationary cost pressures and supply chain challenges to continue ~~to expect to have higher raw material and logistics costs in~~for the remainder of fiscal year ~~2022 as compared to fiscal year 2021.~~2023.

Table of Contents

Gross profit. Gross profit ~~increased $22.5~~decreased $5.6 million, or ~~23.9%~~4.8%, for the thirteen weeks ended November ~~27, 2021~~26, 2022 compared to the thirteen weeks ended November ~~28, 2020, which was primarily driven by the sales volume growth for both the Quest® and Atkins®~~

~~Table of Contents~~

~~brands as discussed above. Gross~~27, 2021. Additionally, gross profit of ~~$116.6~~$111.0 million, or 36.9% of net sales, for the thirteen weeks ended November 26, 2022 decreased 450 basis points from 41.4% of net sales for the thirteen weeks ended November 27, ~~2021 increased 70 basis points from 40.7% of net sales for the thirteen weeks ended November 28, 2020.~~2021. The ~~increase~~decreases in gross profit ~~margin was primarily the result of the price increase which became effective in September 2021 as well as favorable product form~~ and ~~retail channel mix given higher shopper traffic volume within brick and mortar retailers. The increase in~~ gross profit margin ~~was partially offset~~were primarily driven by the unfavorable effects of higher raw material, ~~costs, logistics~~packaging, and co-manufacturing costs and supply chain challenges in the thirteen weeks ended November ~~27, 2021~~26, 2022 as previously discussed. These decreases were partially offset by the favorable effects of the price increase which became effective in the fourth quarter of fiscal year 2022.

Operating expenses. Operating expenses ~~increased $3.7~~remained approximately flat at $58.5 million ~~or 6.7%,~~ for the thirteen weeks ended November 26, 2022 and November 27, 2021 ~~compared to the thirteen weeks ended November 28, 2020~~ due to the following:

•Selling and marketing. Selling and marketing expenses ~~increased $5.3~~decreased $2.0 million, or ~~21.2%~~6.5%, for the thirteen weeks ended November ~~27, 2021~~26, 2022 compared to the thirteen weeks ended November ~~28, 2020. The increase was~~27, 2021, primarily related to ~~additional brand building initiatives for both Atkins® and Quest® in~~ the ~~thirteen weeks ended November 27, 2021 compared~~timing of marketing spend, which was partially offset by increased production costs related to ~~the thirteen weeks ended November 28, 2020.~~

television commercials.

•General and administrative. General and administrative expenses ~~decreased $1.7~~increased $1.9 million, or ~~6.7%~~8.2%, for the thirteen weeks ended November ~~27, 2021~~26, 2022 compared to the thirteen weeks ended November ~~28, 2020.~~27, 2021. The ~~decrease~~increase in general and administrative expenses was primarily attributable to ~~reductions~~a $0.7 million increase in stock-based compensation and increased corporate and employee related expenses. These increases were partially offset by the discontinuation of costs related to business integration activities ~~of $1.2 million~~ and restructuring charges ~~of $2.5~~in the thirteen weeks ended November 26, 2022 compared to costs totaling $0.1 million in the thirteen weeks ended November 27, 2021 compared to the thirteen weeks ended November 28, 2020. These decreases were partially offset by an increase in incentive compensation, including an increase of stock-based compensation of $1.5 million, in the thirteen weeks ended November 27, 2021 compared to the thirteen weeks ended November 28, 2020.

2021.

•Depreciation and amortization. Depreciation and amortization expenses ~~remained approximately flat at~~were $4.3 million for the thirteen weeks ended November ~~27, 2021~~26, 2022 and ~~$4.2 million for the November 28, 2020.~~

~~Interest income~~. ~~Interest income was nominal for each of the thirteen weeks ended~~ November 27, ~~2021 and November 28, 2020.~~2021.

Interest expense. Interest expense ~~decreased $2.0~~increased $0.7 million for the thirteen weeks ended November ~~27, 2021~~26, 2022 compared to the thirteen weeks ended November ~~28, 2020,~~27, 2021, primarily due to the increase in interest rates on our Term Facility (as defined below) to 7.7% as of November 26, 2022 from 4.8% as of November 27, 2021. The increase was partially offset by the effect of principal payments reducing the outstanding balance of the Term Facility ~~(as defined below)~~ to $400.0 million as of November 26, 2022 from $431.5 million as of November 27, ~~2021 from $581.5 million as of November 28, 2020.~~2021. Additionally, interest expense related to the amortization of deferred financing costs and debt discount decreased $0.3 million for the thirteen weeks ended November ~~27, 2021~~26, 2022 compared to the thirteen weeks ended November ~~28, 2020.~~27, 2021.

~~(Loss) gain~~Loss in fair value change of warrant liability. During thirteen weeks ended November 27, 2021, ~~and November 28, 2020,~~ we recorded a non-cash loss of $17.3 million ~~and a non-cash gain of $20.5 million, respectively,~~ related to changes in valuation of our liability-classified warrants issued through a private placement (“Private Warrants”), which iswas primarily driven by movements in our stock price. On January 7, 2022, the Private Warrants were exercised on a cashless basis, resulting in a net issuance of 4,830,761 shares of common stock. As a result, there were no outstanding liability-classified Private Warrants during the thirteen weeks ended November 26, 2022.

~~(Loss) gain~~Gain (loss) on foreign currency transactions. AForeign currency transactions resulted in a gain of $0.1 million and a loss of $0.4 million ~~in foreign currency transactions was recorded~~ for the thirteen weeks ended November 26, 2022 and November 27, 2021, ~~compared to an immaterial foreign currency gain for the thirteen weeks ended November 28, 2020.~~respectively. The variance ~~primarily relates~~is attributable to changes in foreign currency rates related to our international operations.

Income tax expense. Income tax expense ~~increased $4.4~~decreased $3.1 million for the thirteen weeks ended November ~~27, 2021~~26, 2022 compared to the thirteen weeks ended November ~~28, 2020.~~27, 2021. The ~~increase~~decrease in our income tax expense iswas primarily driven by ~~higher~~lower income from operations ~~partially offset by~~and changes in permanent ~~differences.~~differences.

Net income. Net income was $35.9 million for the thirteen weeks ended November 26, 2022, an increase of $14.7 million compared to net income of $21.2 million for the thirteen weeks ended November 27, ~~2021, a decrease of $21.8 million compared to net income of $43.0 million for the thirteen weeks ended November 28, 2020.~~2021. The ~~decrease in net income~~increase was primarily driven by the $17.3 million non-cash fair value loss ~~of $17.3 million~~incurred in the thirteen weeks ended November 27, 2021 ~~compared to a non-cash fair value gain of $20.5 million in the thirteen weeks ended November 28, 2020~~ related to the measurement of our liability-classified Private ~~Warrants, which~~Warrants. The increase in net income was partially offset by ~~increased~~the decreased income from operations driven by the ~~Atkins®~~unfavorable effects of higher raw material and ~~Quest® brand sales volume growth as discussed above.~~co-manufacturing costs and supply chain challenges in the thirteen weeks ended November 26, 2022.

Adjusted EBITDA. Adjusted EBITDA ~~increased $16.9~~decreased $4.8 million, or ~~34.7%~~7.4% for the thirteen weeks ended November 26, 2022 compared to the thirteen weeks ended November 27, 2021, ~~compared to~~driven primarily by the decrease in income from operations as a result of the unfavorable effects of higher raw material and co-manufacturing costs and supply chain challenges in the thirteen weeks ended November ~~28, 2020, driven primarily by sales volume growth for the Atkins® and Quest® brands~~26, 2022 as discussed above. For a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, see “Reconciliation of EBITDA and Adjusted EBITDA” below.

2321

Table of Contents

Reconciliation of EBITDA and Adjusted EBITDA

EBITDA and Adjusted EBITDA are non-GAAP financial measures commonly used in our industry and should not be construed as alternatives to net income as an indicator of operating performance or as alternatives to cash flow provided by operating activities as a measure of liquidity (each as determined in accordance with GAAP). ~~Simply Good Foods~~The Company defines EBITDA as net income or loss before interest income, interest expense, income tax expense, depreciation and amortization, and Adjusted EBITDA as further adjusted to exclude the following items: stock-based compensation expense, integration costs, restructuring costs, gain or loss in fair value change of warrant liability, and other non-core expenses. The Company believes that EBITDA and Adjusted EBITDA, when used in conjunction with net income, are useful to provide additional information to investors. Management of the Company uses EBITDA and Adjusted EBITDA to supplement net income because these measures reflect operating results of the on-going operations, eliminate items that are not directly attributable to the Company’s underlying operating performance, enhance the overall understanding of past financial performance and future prospects, and allow for greater transparency with respect to the key metrics the Company’s management uses in its financial and operational decision making. The Company also believes that EBITDA and Adjusted EBITDA isare frequently used by securities analysts, investors and other interested parties in the evaluation of companies in its industry. EBITDA and Adjusted EBITDA may not be comparable to other similarly titled captions of other companies due to differences in the non-GAAP calculation.

The following unaudited table provides a reconciliation of EBITDA and Adjusted EBITDA to its most directly comparable GAAP measure, which is net income, for the thirteen weeks ended November ~~27, 2021~~26, 2022 and November ~~28, 2020:~~27, 2021:


(In thousands)	(In thousands)	Thirteen Weeks Ended					(In thousands)		Thirteen Weeks Ended
		November 27, 2021		November 28, 2020				(In thousands)			November 26, 2022				November 27, 2021
Net income	Net income	$	21,152	$	42,953						$	35,860			$	21,152
Interest income	Interest income	(1)		(3)						Interest income			(7)				(1)
Interest expense	Interest expense	6,371		8,372						Interest expense			7,055				6,371
Income tax expense	Income tax expense	12,823		8,374						Income tax expense			9,696				12,823
Depreciation and amortization	Depreciation and amortization	4,741		4,513						Depreciation and amortization			4,952				4,741
EBITDA	EBITDA	45,086		64,209						EBITDA			57,556				45,086

Stock-based compensation expense	Stock-based compensation expense	2,605		1,110						Stock-based compensation expense			3,313				2,605

Integration of Quest	Integration of Quest	55		1,246						Integration of Quest			—				55
Restructuring	Restructuring	42		2,519						Restructuring			—				42

Loss (gain) in fair value change of warrant liability		17,317		(20,453)
Loss in fair value change of warrant liability										Loss in fair value change of warrant liability			—				17,317

Other (1)	Other (1)	510		66						Other (1)			(103)				510
Adjusted EBITDA	Adjusted EBITDA	$	65,615	$	48,697					Adjusted EBITDA			$	60,766			$	65,615
(1) Other items consist principally of exchange impact of foreign currency transactions and other expenses.	(1) Other items consist principally of exchange impact of foreign currency transactions and other expenses.					(1) Other items consist principally of exchange impact of foreign currency transactions and other expenses.

Table of Contents

Liquidity and Capital Resources

Overview

We have historically funded our operations with cash flow from operations and, when needed, with borrowings under our Credit Agreement (as defined below). Our principal uses of cash have been working capital, debt service, repurchases of our common stock, and acquisition opportunities.

We had ~~$35.4~~$54.1 million in cash as of November ~~27, 2021.~~26, 2022. We believe our sources of liquidity and capital will be sufficient to finance our continued operations, growth strategy and additional expenses we expect to incur for at least the next twelve months. As circumstances warrant, we may issue debt and/or equity securities from time to time on an opportunistic basis, dependent upon market conditions and available pricing. We make no assurance that we can issue and sell such securities on acceptable terms or at all.

Our material future cash requirements from contractual and other obligations relate primarily to our principal and interest payments for our Term Facility, as defined and discussed below, and our operating and finance leases. Refer to Note 5, Long-Term Debt and Line of Credit, and Note 8, Leases, of the Notes to Unaudited ~~Condensed~~ Consolidated Financial Statements in this Report for additional information related to the expected timing and amount of payments related to our contractual and other obligations.

Debt and Credit Facilities

On July 7, 2017, we entered into a credit agreement with Barclays Bank PLC and other parties (as amended to date, the “Credit Agreement”). The Credit Agreement at that time provided for (i) a term facility of $200.0 million (“Term Facility”) with a seven-year maturity and (ii) a revolving credit facility of up to $75.0 million (the “Revolving Credit Facility”) with a five-year maturity. Substantially

~~Table of Contents~~

concurrent with the consummation of the business combination which formed the Company between Conyers Park Acquisition Corp. and NCP-ATK Holdings, Inc. on July 7, 2017, the full $200.0 million of the Term Facility (the “Term Loan”) was drawn.

Effective as of December 16, 2021, we entered into a third amendment (the “Extension Amendment”) to the Credit Agreement. The Extension Amendment provided for an extension of the stated maturity date of the Revolving Commitments and Revolving Loans (each as defined in the Credit Agreement) from July 7, 2022 to the earlier of (i) 91 days prior to the then-effective maturity date of the Initial Term Loans and (ii) December 16, 2026.

On January 21, 2022, we entered into a repricing amendment (the “2022 Repricing Amendment”) to the Credit Agreement. The 2022 Repricing Amendment, among other things, (i) reduced the interest rate per annum applicable to the Initial Term Loans outstanding under the Credit Agreement immediately prior to the effective date of the 2022 Repricing Amendment, (ii) reset the prepayment premium for the existing Initial Term Loans to apply to Repricing Transactions (as defined in the Credit Agreement) that occur within six months after the effective date of the 2022 Repricing Amendment, and (iii) implemented the Secured Overnight Financing Rate (“SOFR”) and related replacement provisions for the London Interbank Offered Rate (“LIBOR”).

Effective as of the 2022 Repricing Amendment dated January 21, 2022, the interest rate per annum is based on ~~either (i) a~~either:

The Simply Good Foods Company is not a borrower under the Credit Agreement and has not provided a guarantee of the Credit Agreement. Simply Good Foods USA, Inc., is the administrative borrower and certain other subsidiary holding companies are co-borrowers under the Credit Agreement. Each of our domestic subsidiaries that is not a named borrower under the Credit Agreement has provided a guarantee on a secured basis. As security for the payment or performance of the debt under the Credit Agreement, the borrowers and the guarantors have pledged certain equity interests in their respective subsidiaries and granted the lenders a security interest in substantially all of their domestic assets. All guarantors other than Quest Nutrition, LLC are holding companies with no assets other than their investments in their respective subsidiaries.

~~On March 16, 2018 (the “Amendment Date”), we entered into an amendment (the “Repricing Amendment”) to the Credit Agreement. As a result~~

Table of the Repricing Amendment, the interest rate on the Term Loan was reduced and, as of the Amendment Date, such loans had an interest rate equal to, at our option, either LIBOR plus an applicable margin of 3.50% or a base rate plus an applicable margin of 2.50%. The Repricing Amendment did not change the interest rate on the Revolving Credit Facility. The Revolving Credit Facility continued to bear interest based upon our consolidated net leverage ratio as of the last financial statements delivered to the administrative agent. No additional debt was incurred or any proceeds received by us in connection with the Repricing Amendment. The incremental fees paid to the administrative agent are reflected as additional debt discount and are amortized over the terms of the long-term financing agreements using the effective-interest method.

Contents

On November 7, 2019, we entered into a second amendment (the “Incremental Facility Amendment”) to the Credit Agreement to increase the principal borrowed on the Term Facility by $460.0 million. The Term Facility together with the incremental borrowing make up the Initial Term Loans (as defined in the Incremental Facility Amendment) and as of the Amendment No. 2 Effective Date (as defined in the Incremental Facility Amendment), the Initial Term Loans bear interest at a rate equal to, at our option, either LIBOR plus an applicable margin of 3.75% or a base rate plus an applicable margin of 2.75%. The Incremental Facility Amendment was executed to partially finance the acquisition of Quest Nutrition, LLC on November 7, 2019. No amounts under the Term Facility were repaid as a result of the execution of the Incremental Facility Amendment.

The Applicable Rate per annum applicable to the loans under the Credit Agreement Amendment is, with respect to any Initial Term Loan that is an ABR Loan (as defined in the Credit Agreement), 2.75% per annum, and with respect to any Initial Term Loan that is a Eurodollar Loan, 3.75% per annum. The incremental term loans will mature on the maturity date applicable to the Initial Term Loans, which is July 7, 2024.

The Credit Agreement contains certain financial and other covenants that limit our ability to, among other things, incur and/or undertake asset sales and other dispositions, liens, indebtedness, certain acquisitions and investments, consolidations, mergers, reorganizations and other fundamental changes, payment of dividends and other distributions to equity and warrant holders, and prepayments of material subordinated debt, in each case, subject to customary exceptions materially consistent with credit facilities of such type and size. The Revolving Credit Facility has a maximum total net leverage ratio equal to or less than 6.00:1.00 contingent on credit extensions in excess of 30% of the total amount of commitments available under the Revolving Credit Facility. Any failure to comply with the restrictions of the credit facilities may result in an event of default. We were in compliance with all financial covenants as of November ~~27, 2021~~26, 2022 and August ~~28, 2021,~~27, 2022, respectively.

At November ~~27, 2021,~~26, 2022, the outstanding balance of the Term Facility was ~~$431.5~~$400.0 million. We are not required to make principal payments on the Term Facility over the twelve months following the period ended November ~~27, 2021.~~26, 2022. The outstanding balance of the Term Facility is due upon its maturity in July 2024. As of November ~~27, 2021,~~26, 2022, there were no amounts drawn against the Revolving Credit Facility.

Stock Repurchase Program

~~Table~~ On October 21, 2022, we announced that our Board of ~~Contents~~

~~Private Warrants~~Directors had approved the addition of $50.0 million to ~~Purchase Common Stock~~our stock repurchase program, resulting in authorized stock repurchases of up to an aggregate of $150.0 million. During the thirteen weeks ended November 26, 2022, we repurchased 546,346 shares of common stock for $16.4 million, averaging a purchase price per share of $30.11. We did not repurchase any shares of common stock during the thirteen weeks ended November 27, 2021.

As of November ~~27, 2021, we have outstanding liability-classified Private Warrants that allow holders~~26, 2022, approximately $71.5 million remained available for repurchases under our $150.0 million stock repurchase program. Refer to ~~purchase 6,700,000 shares~~Note 10, Stockholders’ Equity, of the ~~Company’s common stock. Such Private Warrants are held by Conyers Park Sponsor, LLC, a~~Notes to Unaudited Consolidated Financial Statements in this Report for additional information related ~~party. Each whole warrant entitles the holder~~ to ~~purchase one share of the Company’s common~~our stock at a price of $11.50 per share. If all Private Warrants are exercised at the $11.50 exercise price per warrant, our cash would increase by $77.1 million. The warrants expire on July 7, 2022 or earlier upon redemption or liquidation, as applicable.repurchase program.

Cash Flows

The following table sets forth the major sources and uses of cash for each of the periods set forth below (in thousands):

Thirteen Weeks Ended
November 27, 2021 November 28, 2020
Net cash (used in) provided by operating activities $ (7,329) $ 15,197
Net cash (used in) provided by investing activities $ (4,377) $ 5,593
Net cash used in financing activities $ (27,992) $ (25,122)


	Thirteen Weeks Ended
	November 26, 2022		November 27, 2021
Net cash provided by (used in) operating activities	$	8,718	$	(7,329)
Net cash used in investing activities	$	(1,238)	$	(4,377)
Net cash used in financing activities	$	(20,761)	$	(27,992)

Operating activities. Our net cash ~~(used in)~~ provided by operating activities ~~decreased $22.5~~increased $16.0 million to ~~$7.3~~$8.7 million for the thirteen weeks ended November 26, 2022 compared to cash used in operating activities of $7.3 million for the thirteen weeks ended November 27, ~~2021 compared to cash provided by operating activities of $15.2 million for the thirteen weeks ended November 28, 2020.~~2021. The ~~decrease~~increase in cash provided by operating activities was primarily attributable to changes in working capital, ~~including $14.0 million~~comprised of changes in accounts receivable, net, ~~$14.2 million of~~inventories, prepaid expenses, accounts payable, and ~~$17.9 million of~~ accrued expenses and other current liabilities, ~~due to~~which are driven by the timing of payments and receipts ~~during~~and seasonal building of inventory. Changes in working capital consumed cash of $47.6 million in the thirteen weeks ended November 26, 2022 compared to $61.4 million of cash consumed in the thirteen weeks ended November 27, 2021. Additionally, ~~seasonal building of inventory levels contributed~~cash paid for taxes decreased $8.8 million to ~~$15.3 million of negative working capital changes in inventory~~an immaterial amount for the thirteen weeks ended November 26, 2022 as compared to the thirteen weeks ended November 27, 2021. These ~~decreases~~increases in cash provided by operating activities were partially offset by the ~~$18.8~~$5.5 million ~~increase~~decrease in income from operations to $52.5 million for the thirteen weeks ended November 26, 2022 as compared to $58.0 million for the thirteen weeks ended November 27, 2021, primarily attributable to ~~retail sales volume growth~~the higher raw material and ~~e-commerce growth for both the Atkins®~~co-manufacturing costs and ~~Quest® brands~~supply chain challenges as discussed in “Results of Operations” above. Additionally, cash paid for interest was $6.4 million in the thirteen weeks ended November 26, 2022, which was an increase of $0.7 million as compared to the $5.7 million paid for interest in the thirteen weeks ended November 27, 2021.

Investing activities. Our net cash used in investing activities was $1.2 million for the thirteen weeks ended November 26, 2022 compared to $4.4 million for the thirteen weeks ended November 27, ~~2021 compared to~~2021. Our net cash ~~provided by~~used in investing activities ~~of $5.6 million~~ for the thirteen weeks ended November ~~28, 2020. Our~~26, 2022 primarily comprised $1.2 million of purchases of property and equipment. The $4.4 million of net cash used in investing activities for the thirteen weeks ended November 27, 2021 primarily comprised $2.7 million of purchases of property and equipment and the issuance of a $1.5 million note receivable. The $5.6 million of net cash provided by investing activities for the thirteen weeks ended November 28, 2020 primarily comprised the $5.8 million of cash proceeds received from the SimplyProtein Sale.

Table of Contents

Financing activities. Our net cash used in financing activities was $20.8 million for the thirteen weeks ended November 26, 2022 compared to $28.0 million for the thirteen weeks ended November 27, ~~2021 compared to $25.1 million~~2021. Net cash used in financing activities for the thirteen weeks ended November ~~28, 2020.~~26, 2022 primarily consisted of $16.4 million in repurchases in common stock, $6.5 million in principal payments on the Term Facility, and $2.3 million in tax payments related to issuance of restricted stock units and performance stock units, partially offset by $4.6 million of cash proceeds received from option exercises. Net cash used in financing activities for the thirteen weeks ended November 27, 2021 primarily consisted of $25.0 million in principal payments on the Term Facility and $3.2 million ofin tax payments related to issuance of restricted stock units and performance stock units. ~~Net cash used in financing activities for the thirteen weeks ended November 28, 2020 primarily consisted of $25.0 million in principal payments on the Term Facility.~~

New Accounting Pronouncements

For a description of critical accounting policies that affect our significant judgments and estimates used in the preparation of our consolidated financial statements, refer to our Annual Report. Refer to Note 2, Summary of Significant Accounting Policies, of our unaudited interim consolidated financial statements in this Report for further information regarding recently issued accounting standards.

2625

Table of Contents

Item 3. Quantitative and Qualitative Disclosures about Market Risk

There were no material changes in our market risk exposure during the thirteen week period ended November ~~27, 2021.~~26, 2022. We continue to expect to experience logistics challenges in our supply chain as well as higher raw material costs, higher freight and logistics costs, and supply chain challenges in fiscal year ~~2022. We~~2023. In addition, current or future governmental policies may increase the risk of inflation and possible economic recession, which could further increase the costs of ingredients, packaging and finished goods for our business as well as negatively effect consumer behavior and demand for our products. As a result, we instituted a price ~~increase~~increases effective in ~~September 2021,~~ the first ~~month~~and fourth quarters of our fiscal year 2022, which management believes, along with productivity initiatives, will enable us to continue to invest in projects that drive growth. We are continuing to assess available alternatives to mitigate potential input cost inflation for fiscal year 2022. However, there can be no assurance that the price increases will fully offset the effects of higher raw material and supply and distribution costs on our results of operations and financial condition. For a discussion of our market risks, see “Quantitative and Qualitative Disclosures About Market Risk” in Part II, Item 7A of our Annual Report.

Item 4. Controls and Procedures

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required financial disclosures.

Management, including the participation of our Chief Executive Officer and our Chief Financial Officer, conducted an evaluation (pursuant to Rule 13a-15(b) under the Exchange Act) of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of November ~~27, 2021,~~26, 2022, the Company’s disclosure controls and procedures were effective

Changes in Internal Control over Financial Reporting

There were no changes in our internal controls over financial reporting during the quarter ended November ~~27, 2021~~26, 2022 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

Inherent Limitations on Effectiveness of Controls

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Additionally, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

2726

Table of Contents

PART II. Other Information

Item 1. Legal Proceedings

From time to time, we have been and may again become involved in legal proceedings arising in the ordinary course of our business. We are not presently a party to any litigation that we believe to be material and we are not aware of any pending or threatened litigation against us that we believe could have a material adverse effect on our business, operating results, financial condition or cash flows.

Item 1A. Risk Factors

Readers should carefully consider the factors discussed in Part I, Item 1A. “Risk Factors” in our Annual Report, which could materially affect our business, financial condition, cash flows or future results. There have been no material changes in our risk factors included in our Annual Report. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially adversely affect our business, financial condition or future results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

~~None.~~Issuer Purchases of Equity Securities


				Total Number of Shares Purchased	Maximum Dollar Value of Shares
	Total Number of	Average Price		as Part of Publicly Announced	That May Yet Be Purchased Under
Period	Shares Purchased	Paid Per Share		Plans or Programs(1)	the Plans or Programs(1)
August 28, 2022 - September 24, 2022	507,494	$	30.06	507,494	$	22,737,632
September 25, 2022 - October 22, 2022	38,852	30.66		38,852	71,546,585
October 23, 2022 - November 26, 2022	—	—		—	71,546,585
Total	546,346	$	30.11	546,346	$	71,546,585

(1) We adopted a $50.0 million stock repurchase program on November 13, 2018. On April 13, 2022, and October 21, 2022, we announced that our Board of Directors had approved the addition of $50.0 million and $50.0 million, respectively, to our stock repurchase program, resulting in authorized stock repurchases of up to an aggregate of $150.0 million. As of November 26, 2022, approximately $71.5 million remained available under the stock repurchase program. Under the stock repurchase program, we may repurchase shares from time to time in the open market or in privately negotiated transactions. The stock repurchase program does not obligate us to acquire any specific number of shares or acquire shares over any specific period of time. We may suspend or discontinue the stock repurchase program at any time, and the stock repurchase program does not have an expiration date.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

None.

2827

Table of Contents

Item 6. Exhibits


Exhibit No.						Document
10.1†						Offer Letter between The Simply Good Foods Company and Shaun Mara, dated October 16, 2022 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on October 27, 2022 ).
31.1*						Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
31.2*						Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
32.1**						Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes Oxley Act.
~~10.1~~						Amendment No. 3 (Extension Amendment), dated as of December 16, 2021, by and among Atkins Intermediate Holdings, LLC, a Delaware limited liability company, Conyers Park Acquisition Corp., a Delaware corporation, Simply Good Foods USA, Inc., a New York corporation, Atkins Nutritionals Holdings, Inc., a Delaware corporation, Atkins Nutritionals Holdings II, Inc., a Delaware corporation, NCP-ATK Holdings, Inc., a Delaware corporation and the financial institutions party thereto as Consenting Lenders and the Replacement Lender and Barclays Bank PLC, as administrative agent.
~~101.INS~~101.INS*						XBRL Instance Document
~~101.SCH~~101.SCH*						XBRL Taxonomy Extension Schema Document
~~101.CAL~~101.CAL*						XBRL Taxonomy Extension Calculation Linkbase Document
~~101.DEF~~101.DEF*						XBRL Taxonomy Extension Definition Linkbase Document
~~101.LAB~~101.LAB*						XBRL Taxonomy Extension Label Linkbase Document
~~101.PRE~~101.PRE*						XBRL Taxonomy Extension Presentation Linkbase Document
104						Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).
* Filed herewith.
** Furnished herewith.
† Indicates a management contract or compensatory plan.

2928

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

By:

THE SIMPLY GOOD FOODS COMPANY

/s/ Timothy A. Matthews

Date:

January 5, ~~2022~~2023

Name:

Timothy A. Matthews

Title:

Vice President, Controller, and Chief Accounting Officer

(Principal Accounting Officer)

3029


	November 27, 2021			November 28, 2020
Exercise Price	$	11.50		$	11.50
Stock Price	$	37.93		$	22.36
Dividend Yield	—		%	—		%
Expected Term (in Years)	0.61			1.60
Risk-Free Interest Rate	0.15		%	0.14		%
Expected Volatility	27.34		%	25.60		%
Per Share Value of Warrants	$	26.44		$	10.92


(In thousands)	Termination benefits and severance		Other		Restructuring liability
Balance as of August 28, 2021	$	851	$	—	$	851
Charges	44		28		72
Cash payments	(748)		(28)		(776)

Balance as of November 27, 2021	$	147	$	—	$	147